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ABSTRACT
CHARACTERIZATION OF THE HUMAN CYTOMEGALOVIRUS UL75 LATE
GENE PROMOTER
Bernard J.P. McWatters 
Old Dominion University, 2001 
Chair: Dr. Julie A. Kerry
Gene expression during productive infection by the human cytomegalovirus 
(HCMV) occurs in an ordered and sequential manner, beginning with immediate early 
(IE), then early (E) and finally late (L) gene expression. Significant work has addressed 
the regulation of EE and E gene expression while relatively little work has addressed the 
control of late gene expression. In order to further address HCMV late gene expression, 
the promoter of the HCMV UL75 (glycoprotein H, gH) late gene was characterized. The 
data obtained in this study were combined with observations made in two other studies 
that have addressed HCMV late gene expression to develop a model of the regulation of 
HCMV late gene expression.
The gH promoter and numerous promoter mutants were cloned into a reporter 
vector to address sequences responsible for the regulation of gene expression. These gH 
promoter constructs were transfected into human fibroblasts and subsequently infected 
with HCMV. Our data revealed that viral infection was necessary to activate expression 
from the gH promoter, confirming observations made in other HCMV late gene studies. 
Deletion analysis of promoter sequences revealed that sequences upstream of the TATA 
element in the gH promoter are not necessary for wild type levels of gene expression. 
Further deletion of sequences downstream of the mRNA cap site (+1) revealed the 
presence of upstream control elements that were masked by the dominant downstream 
activation domain. Mutational analysis demonstrated that a PEA3 element present in this
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
downstream domain is important for promoter activation. In addition, gel shift analysis 
revealed direct protein binding to the PEA3 element. Deletion and mutational analysis 
also revealed that multiple sequence elements between -38 and +14 are responsible for 
gH promoter activation. Gel shift analysis using promoter sequences from this region as 
probes and competitors revealed protein binding to a DAS element at +1 to +6. Despite 
direct protein binding, transfection analysis in fibroblasts revealed that the DAS element 
was not important for promoter activation, however it may be important in other cell 
types. Gel shift analysis also demonstrated a protein binding to promoter sequences 
between +1 and +35 at late times of infection that is likely involved in activation. This 
analysis reveals the complexity of gH promoter regulation as well as demonstrating 
similarities between all three HCMV late gene promoters characterized thus far.
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The Human Cytomegalovirus (HCMV) is a herpesvirus that is an important 
human pathogen. The exact origin of the virus is not known, but even an ancient and 
isolated population of Tiriyo Indians of Brazil has been infected with this ubiquitous 
pathogen (reviewed in Britt, 1996). Infection with HCMV is usually subclinical and 
often goes unnoticed in an immunocompetent host. This fact has resulted in our poor 
understanding of the origin and history of HCMV.
The clinical manifestation of HCMV in infants led to naming of the virus. In 
1904, Jesionek and Rippert each observed enlarged cells with intranuclear inclusions in 
infants that had died from this unknown disease (reviewed in Britt, 1996). The 
observation of these cellular changes in patients that had died from infection led to the 
term “cytomegalic inclusion disease” (CID). This term was coined prior to the 
knowledge that a virus was the causative agent for this disease. In 1921, Lipshutz 
noticed the similarity of CID to herpetic lesions and was the first to hypothesize that a 
virus caused CED. That same year Goodpasture and Talbot noticed the similarity of CED 
cells extracted from the parotid gland of infants that had died to “giant cells” that had 
inclusions from the parotid gland of guinea pigs. In 1926, Cole and Kuttner 
demonstrated that the salivary glands of guinea pigs with cytomegalia contained a 
filterable virus. This same effect was characterized in humans and Farber and Wolbach
This dissertation follows the format of the journal Virology.
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2showed that a similar pathologic disease to that characterized in guinea pigs was 
relatively common, occurring in a significant portion of infants that had died from a 
variety of illnesses (reviewed in Britt, 1996).
The discovery of HCMV was accomplished by 3 separate groups working 
independently in 1957. Each group observed patient samples with CID. These samples 
contained an agent that could be used to infect human fibroblast cells (reviewed in Britt, 
1996). When the infected fibroblast cells were stained, inclusions and cytopathic effects 
were seen identical to those observed from patients dying from CED. The term 
cytomegalovirus was coined by Weller to describe the effects of infection with the vims 
(reviewed in Britt, 1996).
Recent developments in medicine have renewed interest in HCMV, including the 
AIDS pandemic, increases in organ transplants, and bone marrow transplants. Medical 
procedures and diseases such as these can lead to an immunocompromised state, allowing 
reactivation of HCMV in an infected host. HCMV infection is quite prevalent throughout 
the world. The Centers for Disease Control and Prevention statistics indicate that as 
many as 85% of the US adult population are infected. Unchecked reactivation in an 
immunocompromised host can result in the death of that patient. Infection of a fetus can 
also lead to severe birth defects (reviewed in Britt, 1996). Profound outcomes such as 
death or severe birth defects necessitate the further research of this significant human 
pathogen.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3HCMV Disease
HCMV has the ability to infect almost all organs and tissues in the human host 
because of the large number of cell types that can support productive infection in vivo. 
The primary cell types infected include epithelial cells, endothelial cells, and fibroblasts, 
which are distributed throughout the body (reviewed in Sinzger and Jahn, 1996). 
Differentiated macrophages support productive infection (Ibanez et al., 1991) and 
circulating monocytes are latently infected with HCMV (Soderberg-Naucler, Fish, and 
Nelson, 1997). These circulating monocytes allow the virus to spread throughout the 
infected host. Other cells that support HCMV infection in vivo include neurons, 
hepatocytes, and smooth muscle cells in the gastrointestinal tract (Sinzger et al., 1995). 
Evidence for viral infection has been detected in several organs throughout the body 
(Toorkey and Carrigan, 1989). These organs include the kidneys, liver, heart, brain, 
salivary gland, retinas, several organs of the gastrointestinal tract, and lungs. The organs 
that HCMV infects accounts for the pathogenic effects that the virus has in 
immunocompromised patients. For example, infection of the retina causes CMV retinitis, 
which can lead to blindness. Similarly, unchecked infection of the liver can cause 
hepatitis (reviewed in Sinzger and Jahn, 1996). In contrast, the most severe outcome 
from infection of an immunocompetent host is a disease state that is clinically 
indistinguishable from mononucleosis (reviewed in Britt, 1996).
HCMV is often acquired by the host early in life. Infectious virus can be found in 
several body fluids that can serve as vehicles for horizontal spread of the virus. The 
fluids in which HCMV can be detected at various times throughout the lifetime of an 
infected host are saliva, urine, cervical fluid, vaginal excretions, semen, breast milk,
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4tears, feces, and blood (reviewed in Britt, 1996). These fluids give an indication of how 
the virus can be spread. Often, an infected mother can infect an infant when shedding 
infectious virus in the breast milk. Infants can also be infected by the mother during 
birth. The virus is also spread when a population is in close contact, such as in day care 
centers, where children and staff are often exposed to potentially infected saliva, urine, 
tears, feces and blood. HCMV can also be sexually transmitted via infectious cervical 
fluid, vaginal excretions, or semen (reviewed in Britt, 1996).
HCMV infects a developing fetus by crossing the placenta, usually during 
primary infection of the mother. In such cases the transmission rate to the fetus can be as 
high as 52% and approximately 15% of these congenitally infected infants developed 
clinically apparent disease (Stagno et al., 1982). The immune response of a mother 
infected with HCMV prior to conception can block infection of the fetus in many cases.
In this situation, reactivation of the virus results in a transmission rate to the fetus of 
between 0.2% and 2% (reviewed in Britt, 1996), although recent evidence suggests that 
the transmission rate may be much higher (Boppana et al., 2001). The evidence in this 
study indicates that reinfection of a mother, with a new strain of HCMV can result in 
fetal transmission. In this study, the antibodies generated against glycoprotein H were 
characterized for strain specificity. In congenital HCMV cases where the mother was 
known to have prior immunity, 62% of the mothers had antibodies with different strain 
specifities (Boppana et al., 2001). Morbidity resulting from infection of the fetus can 
manifest in neurological developmental problems that can lead to deafness, blindness, or 
varying degrees of mental retardation. Severe cases can result in the death of the fetus 
(Ahlfors, Ivarsson, and Harris, 1999). However, several studies indicate that infection of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5a fetus in utero does not necessarily result in disease (Ahlfors, Ivarsson, and Harris, 1999; 
Yow et al., 1988). For example, sets of twins that were congenitally infected with HCMV 
developed varying levels of disease (Ahlfors, Ivarsson, and Nilsson, 1988). The cause of 
the different outcomes from fetal infection with CMV are not known, but possible 
differences that could affect the outcome include the immune response of the mother, 
infectious dose of virus or the stage of development at which the fetus was infected.
HCMV infection of an immunocompromised patient can also result in severe 
morbidity and mortality. The disease state is a result of reactivation that is unchecked by 
the immune system or a primary infection. Diseases associated with HCMV infection in 
immunocompromised patients can be found in almost every organ system, but primarily 
in the lung, the gastrointestinal tract, and the central nervous system (reviewed in Britt, 
1996). HCMV is often associated with the development of AIDS in HTV infected 
patients, suggesting that HCMV may be a contributing factor in the progression of AIDS 
(Webster et al., 1989). Patients can be treated with gancyclovir for the infection but 
cytomegalovirus can become resistant to this antiviral drug. Replication of HCMV that is 
untreated or resistant to antivirals can result in the death of the patient. Together these 
studies demonstrate that HCMV is a significant pathogen. Complete characterization of 
this virus is therefore necessary to prevent the disease and death that is associated with 
viral infection.
Viral classification and structure
HCMV, which is also known as human herpes virus 5 (HHV5) is a member of the 
Herpesviridae family. Herpesviruses have similar structural characteristics that define the 
family. The genome of herpesviruses is a linear DNA molecule between 120 and 230
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6kbp in length (reviewed by Roizman, 1996). This linear DNA molecule is surrounded by 
a proteinaceous capsid, made up of 162 individual capsomeres (reviewed by Roizman, 
1996). There is an amorphous layer surrounding the capsid called the tegument or 
matrix, which fills the space between the capsid and the envelope. The envelope of 
Herpesviridae is acquired by the virus from the host cell and is modified with viral 
glycoproteins. These glycoproteins are responsible for the attachment and penetration of 
the virus into the host cell. A number of these glycoproteins share significant homologies 
throughout the herpesvirus subfamilies (reviewed by Roizman, 1996).
Herpesviruses have been classified into three main subfamilies, alpha, beta and 
gammaherpesvirinae. They are grouped according to their biological properties, 
sequence homologies and arrangements, and relatedness of certain viral proteins 
(reviewed by Roizman, 1996). The alphaherpesvirinae subfamily has a variable host 
range, a rapid reproductive cycle in vitro and in vivo, effective destruction of the host cell 
and the ability to establish latency in sensory ganglia. The prototypical alphaherpesvirus 
is herpes simplex virus 1 (HSV1). The betaherpesvirinae subfamily, which includes 
HCMV, has a restricted host range and is typically species specific. The reproductive 
cycle of the betaherpesviruses is much slower than the alphaherpesviruses. The third and 
final herpes virus subfamily is the gammaherpesvirinae. Gammaherpesviruses have 
intermediate host specificity, infecting various hosts within a family or order of the 
natural host. In cell culture, these viruses will replicate in Iymphoblastoid cells and some 
will cause lytic infections in epithelial cells or fibroblasts. The herpesviruses have 
significant similarities based on genome structure, homologies amongst many of the viral 
proteins and the replication cycle. Despite the similarities between the herpesviruses, the
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unique biology of each group contributes to their classification as subfamilies (reviewed 
by Roizman, 1996).
HCMV has the largest genome in the herpesvirus family, approximately 230 
kilobases (kb) in laboratory strains and even larger in clinical isolates (Cha et al., 1996). 
The entire genome of the AD 169 laboratory strain of HCMV has been sequenced and has 
allowed a thorough search for potential open reading frames (ORF). Within this large 
viral genome there are 208 potential ORFs, many of which encode proteins that have 
significant homology with well characterized proteins from other herpesviruses (Chee et 
al., 1990). The genome of HCMV has an organization that is unique among the 
betaherpesviruses. It has a class E genome structure that was first characterized in HSV. 
The basic structure of this genome can be seen in figure 1.
UL Us
FIG 1. A linear representation of the HCMV genome. The HCMV genome is 230 Kb in 
length and contains approximately 200 open reading frames (ORF). This diagram of the 
viral genome indicates that there is a unique long (Ul) and unique short (Us) portion of 
the genome. The genes contained within the Us and Ul portions of the genome have 
been numbered according to their position within the genome. The thick lines within the 
diagram indicate inverted and direct repeat sequences present at the ends of the ULand Us 
sequences.
In this structure there are unique long (UL) and unique short (US) portions of the 
genome. The approximately 208 ORFs are designated according to their position within 
the genome. These titles designate the position of the ORFs by indicating in which 
segment of the virus it occurs and the order in which it occurs according to the original
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8sequence. An example of this would be the glycoprotein H ORF designated UL75, 
indicating that the gene is found in the UL portion of the genome, 75 ORFs from the left 
end of the UL genome segment as described by Chee et al. At the ends of the US and UL 
segments of the genome, there are direct and inverted repeat segments. These repeated 
sequences allow the UL and US portions of the genome to reverse orientations.
Therefore, the genome can exist as any one of four isomers. This could be significant 
due to the fact that there are proteins expressed from the repeated regions, such as 
IRS1/TRS1 (Chee et al., 1990). Rearrangement of these results in changes in the proteins 
expressed from these specific regions. This could also change the level of expression of 
some genes due to the fact that enhancer and promoter sequences that exist within the 
HCMV genome are rearranged. Examples of this have been reported in HSV 1 
(Bohenzky et al., 1993), which has a genome with the same basic structure as the HCMV 
genome (figure 1).
The HCMV icosahedral capsid is the proteinaceous layer that surrounds the viral 
genome. There are 4 major proteins that are in the 162 hexameric capsomeres that make 
up the capsid. These are the major capsid protein (MCP, UL86), the minor capsid protein 
(mCP, UL85), the mCP binding protein (mCP-BP, UL46) and the smallest capsid protein 
(SCP, UL48/49). The largest and most abundant of the capsid proteins is the MCP, which 
has a mass of 154 kilodaltons (kd) and comprises about 90% of the protein mass of the 
viral capsid (reviewed in (Gibson, 1996). The entire capsid is approximately 116 nm in 
diameter and is surrounded by the viral tegument or matrix. The HCMV tegument 
contains approximately 40% of the total protein mass of the infectious viral particle and a 
majority of the tegument proteins are phosphoproteins. The lower matrix protein (LM,
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9pp65, UL83), is the most abundant protein in the viral tegument but the exact function of 
this protein is not known. Another protein in the viral tegument is the upper matrix 
protein (pp71, UL82). pp71 is involved with activation of HCMV promoters (Chau, 
Vanson, et al. 1999) possibly via interaction with viral immediate early proteins (Kerry, 
unpublished data). Another interesting structural feature of HCMV is the incorporation 
of cellular and viral mRNAs in the virion (Greijer, Dekkers, and Middeldorp, 2000). The 
function and necessity of this RNA in viral replication is unknown.
The HCMV envelope surrounds the viral tegument and is acquired from the host 
cell. This membrane is modified primarily with viral glycoproteins that are responsible 
for viral attachment and penetration. The most abundant glycoprotein in the viral 
envelope is glycoprotein B (gB, UL55). This HCMV protein was first identified as gB 
because of the significant homology that it shares with gB from several other herpes 
viruses. The function of HCMV gB has not been directly determined, but due to its 
significant homology with HSV gB its function can be deduced. HSV gB deletion 
mutants have shown that gB is involved in attachment and fusion of the viral and host 
cell membranes. Antibodies to HCMV gB can block attachment and penetration of the 
virus in a cell culture system and these antibodies are detected in patients infected with 
HCMV (Hamilton et al., 1997). These facts indicate that an antibody response to HCMV 
gB may be involved in viral neutralization in an infected host.
Glycoprotein H
The HCMV glycoprotein H (gH, UL75) is part of a three protein complex known 
as gCm , that also contains gL (UL115) and gO (UL74) (Huber and Compton, 1999).
The gH glycoprotein is also conserved throughout known herpes viruses and plays an
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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essential role in replication. The role of gH has been clearly demonstrated in herpes 
simplex virus (HSV). An HSV mutant containing a deletion of the gH coding region was 
generated and characterized in cell culture. This deletion mutant was constructed by 
generating a complementing cell line that expressed HSV gH. Once the deleted virus was 
generated, it was used to infect wild type Vero cells. While this virus was noninfectious, 
treatment of cells with the gH deleted virus blocked subsequent infection with wild type 
HSV. Based on these data, the authors postulated that gH played a role in cell fusion 
(Forrester et al., 1992). Recent evidence demonstrates that HCMV gH is essential for 
viral replication. This investigation utilized bacterial artificial chromosomes (BAC) to 
generate transposon insertion mutants in viral glycoprotein open reading frames including 
gH. This study strongly suggested that glycoproteins B, H, M, and L are essential for 
viral replication (Hobom et al., 2000). Glycoprotein O, one of the other glycoproteins in 
the gCm complex along with gH, was demonstrated to affect replication but was not 
essential for viral replication in cell culture.
The role of HCMV gH has not been directly demonstrated but evidence suggests 
that it plays an essential role in viral-host membrane fusion. This evidence consists 
mainly of cell culture assays in which antibodies to gH can block the spread of infection 
in cell culture (Hamilton, 1997). These antibodies do not completely block attachment of 
the virus to the host cell receptor but they do block the ability of the viral membrane to 
fuse with the plasma membrane of the host cell. Antibodies to gH can be detected in 
nearly 100% of all seropositive individuals and a majority of detectable virus neutralizing 
antibodies are to gH. In summary, evidence suggests that gH plays a critical role in the 
viral replication cycle and is an important target for the host immune response to HCMV.




The initial step of HCMV infection is the attachment of the virus to a permissive 
host cell. Direct interaction of glycoproteins on the viral envelope with one or more cell 
surface receptors allows virus attachment. gB is thought to be one of the major viral 
proteins involved in attachment. The initial interaction of HCMV occurs when gB 
(Compton, Nowlin, and Cooper, 1993) and the gcEI complex (Kari and Gehrz, 1993) 
interact with heparin sulfate proteoglycan on the cell surface with low affinity. This 
interaction likely orients the envelope glycoproteins with high affinity receptors on the 
cell surface. These cellular receptor(s) for HCMV have not yet been determined but 
candidate proteins have been identified including a 30 kd and a 92.5 kd protein (reviewed 
by (Mocarski, 1996). The 92.5 kd cell surface protein is thought to be the receptor for gH 
and interaction with this receptor helps to initiate the fusion of the viral envelope with the 
host cell membrane (Keay and Baldwin, 1991). Antibodies to HCMV gH can block the 
spread of infection in cell culture without completely blocking attachment of the virus to 
the host (Hamilton et al., 1997). This further implicates gH as being important in virus 
host membrane fusion. Because gH is also a part of the three glycoprotein gCHI complex 
(Huber and Compton, 1999), the other glycoproteins in this complex may have a role in 
the function of gH. One of the other glycoproteins in this complex, gL was determined to 
be essential for the transport of gH to the surface of the viral envelope (Milne, Paterson, 
and Booth, 1998). The function of a number of HCMV surface glycoproteins is not 
known, so none of the glycoproteins can be eliminated as being involved in viral 
attachment or penetration, but gH has been demonstrated to be critical in this process and
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is therefore essential for initiation of HCMV infection. Attachment and penetration are 
thought to occur in numerous cell types, but this does not necessarily lead to productive 
infection. The subsequent events in the replication cycle are thought to limit the cell 
types that can be productively infected by HCMV.
Once the virus has penetrated the cell membrane, in order to generate a productive 
infection, the viral genome must enter the host cell nucleus. The exact mechanism of 
viral transport to the nucleus is not known but the viral capsid can be detected in the host 
cell within 5 minutes of exposure (reviewed by (Mocarski, 1996). The viral DNA then 
enters the nucleus through nuclear pores. Proteins from the viral tegument are also 
transported to the nucleus, and are involved in regulation of viral gene expression (Chau, 
Vanson, and Kerry, 1999; Liu and Stinski, 1992). The earliest expression of HCMV viral 
genes can subsequently be detected within 20 to 30 minutes of infection (reviewed in 
Mocarski 1996). The expression of viral mRNA is carried out by cellular RNA 
polymerase II. Evidence of direct binding to the HCMV major immediate early promoter 
(M3EP) sequences in vitro of the basal transcription machinery, namely the TATA 
binding protein (TBP) has been demonstrated (Jupp et al., 1993). These studies showed 
that the basal transcriptional machinery including RNA polymerase II is necessary for 
expression of viral genes. Transcription factors that are active in the nucleus are also 
necessary to express viral genes (reviewed by (Meier and Stinski, 1996; Spector, 1996). 
This combined evidence demonstrates that entry of viral DNA into the host cell nucleus 
is necessary to generate a productive infection.
As previously mentioned, once a permissive cell is exposed to virus, viral gene 
expression can be detected within 30 minutes. The expression of viral mRNAs occurs in
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a coordinated cascade in the host cell consisting of immediate early (IE), early (E) and 
late (L) gene expression. The IE genes are expressed first in permissively infected cells 
without de novo protein synthesis. The EE proteins regulate subsequent gene expression 
and their presence is required for the expression of early genes. The most abundant IE 
mRNAs are transcribed from the UL122-123 gene region (reviewed in Meier and 
Stinski, 1996). The other EE gene regions in HCMV are UL36-38, TRS1-IRS I, UL69 
and US3. The genes expressed from UL122-123 are considered the major immediate 
early (MIE) genes and their expression is controlled by the MIE promoter (MIEP) as well 
as an upstream enhancer and modulator. Expression of the MIE genes is regulated by 
both viral and cellular proteins (reviewed in Meier and Stinski 1996). Cellular 
transcription factors such as CREB/ATF, NF-kB, and Sp-1 can bind to upstream 
sequences in the MEE enhancer to activate transcription (reviewed in Meier and Stinski
1996). Viral proteins can also activate (UL123, IE72) or repress (UL122,1E86) 
transcription of the MIE genes (reviewed in Meier and Stinski 1996). The presence of 
the MEE proteins is necessary to activate early gene expression and allow the virus to 
progress into the early stage of the viral replication cycle. The early viral proteins are 
required for viral DNA replication. Cellular transcription factors such as CREB/ATF, 
jun/fos, and Sp-1 have also been shown to contribute to the activation of early promoters 
(reviewed in Spector 1996). Late genes are expressed after viral DNA replication and 
encode viral structural proteins. These include proteins in the capsid such as the major 
capsid protein (MCP), the tegument such as pp65, and envelope glycoproteins such as gB 
and gH. Once the viral DNA has replicated and the viral structural proteins have been 
translated, virus assembly can occur.
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The exact mechanism by which viral assembly occurs is still under investigation. 
Preliminary assembly of capsid subunits occurs in the cytoplasm and these subunits are 
transported to the nucleus (Wood et al., 1997). Capsid assembly and association with 
viral DNA occurs in the nucleus (reviewed in Gibson, 1996). HCMV must then acquire 
the tegument. The location and mechanism of tegument assembly is less clear. Evidence 
has indicated that proteins in the viral tegument including pp71 (Hensel et al., 1996) and 
ppl50 (Hensel et al., 1995) localize to the nucleus after infection. Recent evidence 
looking at the cellular localization of the tegument protein pp28 (UL99) suggests that 
portions of the assembly process occur in the cytoplasm as well as in the endoplasmic 
reticulum-Golgi-intermediate compartment, a cellular compartment involved in the 
secretory process in the cell. The pp28 protein is myristoylated and membrane 
associated, and eventually ends up in the viral tegument (Sanchez et al., 2000). These 
facts may hold clues to the assembly and egress of HCMV from the cell, but more 
investigation is necessary to determine the exact mechanism of viral assembly. The virus 
must then acquire an envelope via a mechanism that is still open to debate. The final 
viral envelope may come from the inner nuclear membrane or may be acquired from the 
host cell membrane, but data suggests that at least a portion of the assembly process is 
cytoplasmic (Sanchez, Sztul, and Britt, 2000). This indicates that the final viral envelope 
is from the cell membrane, but more evidence is necessary to confirm this possibility. 
Much more investigation is required to determine the exact mechanism of HCMV 
assembly that leads to the production of infectious viral particles.
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Regulation of Gene Expression
HCMV infection of a permissive cell results in a specific gene expression cascade 
that will result in a productive infection. This expression cascade begins when the virus 
binds to the cell surface. When whole virus or glycoproteins B or H bind to the cell 
surface, specific transcription factors are expressed at higher levels, presumably via 
activation of a cellular signal transduction pathway stimulated when the viral 
glycoproteins interact with the HCMV receptor. One study directly demonstrated that 
cellular transcription factors Sp-1 and NF-kB are expressed at much higher levels when 
the cells were either infected or treated with recombinant gB or gH (Yurochko et al.,
1997). Sp-1 and NF-kB are directly involved in the activation of the viral gene 
expression cascade (reviewed in Meier and Stinski 1996). This expression cascade of 
viral genes in HCMV infected cells begins with the expression of immediate early (BE) 
genes, followed by early (E) genes, and finally late (L) genes.
Most of the assays described below that were performed to evaluate viral 
promoter function are transient assays. These assays utilize plasmid constructs 
containing viral promoter fragments driving the expression of reporter proteins such as 
chloramphenicol acetyl transferase (CAT) that are transfected into cells. These promoter 
constructs are activated by cotransfection with plasmids containing portions of the viral 
genome that express proteins necessary to activate the promoter or by infection with 
whole virus. The evaluation of some viral promoters has been accomplished by 
generating recombinant viral promoter constructs (Chau, Vanson, and Kerry, 1999;
Kohler et al., 1994; Rodems, Clark, and Spector, 1998)). The generation of recombinant 
vims has the advantage of evaluating gene expression in the context of the vims. The
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reason that recombinant viruses are not more widely used is that they are quite laborious 
and difficult to generate and in some cases the correct recombinant virus cannot be 
generated (Cageao, personal communication). For this reason, transient assays are 
widely used to evaluate HCMV promoter function.
Immediate Early Gene Expression
The IE genes are the first viral genes expressed in permissively infected cells.
The expression of the IE genes is regulated in part by the cellular transcription factors 
that were activated when the virus bound to its cell surface receptor (Yurochko, Hwang et 
al. 1997). The most abundant EE mRNAs are transcribed from the UL122-123 gene 
region (reviewed in Meier and Stinski, 1996). These genes are considered the major 
immediate early (MIE) genes and their expression is controlled by the MIE promoter 
(MIEP) as well as an upstream enhancer and modulator. Cellular transcription factors 
such as CREB/ATF or those activated by the binding of the virus to the cell surface, NF- 
kB and Sp-1 can bind to upstream sequences in the MIE enhancer to activate 
transcription (reviewed in Meier and Stinski, 1996). There is a single RNA expressed 
from the MIE gene region at immediate early times and the multiple resulting gene 
products are generated by alternate splicing (Stenberg, Witte, and Stinski, 1985). The IE 
proteins regulate subsequent gene expression and their presence is required for the 
expression of early genes (reviewed in (Stenberg, 1996). Viral proteins can also activate 
(UL123) or repress (UL122) transcription of the MDE genes (reviewed in Meier and 
Stinski, 1996). The UL123 mRNA is the first that can be detected during infection of a 
permissive cell and is also referred to as EE 1 or IE72. IE72 is involved in the activation 
of its own promoter as well as activation of several early genes (reviewed in Spector,
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1996). The UL123 gene expresses another major IE protein called IE2 or EE86. This 86 
kd protein is involved in repression of its own promoter as well as activation of numerous 
early promoters (reviewed in Spector, 1996). The presence of the MIE proteins is 
necessary to activate early gene expression and allow the virus to progress into the early 
stage of the viral replication cycle.
Early Gene Expression
The early viral proteins include the proteins that are directly involved in viral 
DNA replication and their expression is therefore critical for viral infection to progress. 
The MIE proteins are required for the activation of early promoters including the HCMV 
DNA polymerase (UL54) promoter. IE86 and IE72 can each contribute to the activation 
individually, but cooperative interaction greatly increases the activation of the 
polymerase promoter (Stenberg et al., 1990). Cellular transcription factors such as 
CREB/ATF, jun/fos, Sp-land members of the ets family of transcription factors have also 
been shown to contribute to the activation of early promoters (Chen and Stinski, 2000; 
Kerry et al., 1997b; Rodems, Clark, and Spector, 1998).
The presence of IE86 is required to activate the expression of HCMV early genes. 
The activation of early gene expression from early promoters by EE86 can occur by direct 
DNA binding and by protein-protein interaction with cellular transcription factors 
including c-Jun, c-Fos and JunB (Scully et al., 1995). The interaction of cellular 
transcription factors and EE86 could stabilize the transcription initiation complex and 
along with other cellular proteins such as ATF-1 (Kerry et al., 1997b) can activate the 
transcription of the viral DNA polymerase. Another example of an HCMV early gene 
promoter is the UL4 promoter. This promoter contains a putative binding site for IE86 as
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well as binding sites for NF-Y and the ets transcription factor Elk-1 that positively 
regulate the expression of UL4 (Chen and Stinski, 2000). EE86 may also enhance 
transcription by direct interaction with viral factors including pp71 (Kerry, unpublished 
data).
All of the data described above in addition to other early promoters that have been 
characterized (Klucher, Rabert, and Spector, 1989; Wade, Klucher, and Spector, 1992) 
have allowed for the generation of a model for HCMV early gene expression. The early 
promoters described require sequences upstream of the TATA element that include 
binding elements for cellular transcription factors. These cellular transcription factors 
interact with the basal transcription complex via a bridge provided by HCMV IE86. The 
activation by IE86 is enhanced by the additional interaction of HCMV EE72. IE86 has 
also been shown to interact with histone acetylases (Bryant et al., 2000), which could 
affect DNA structure and assist in activation by IE86. The combination of these factors 
generates activated expression of HCMV early genes. This has been confirmed by 
recombinant virus studies. For example, a recombinant virus containing the viral DNA 
polymerase early promoter was generated and evaluated for promoter function. This 
study confirmed much of the transient transfection data that indicated that promoter 
sequences upstream of the UL54 5’ mRNA cap site are required for wild type levels of 
expression (Kerry et al., 1996; Kerry et al., 1997a; Kohler et al., 1994). As can be seen, 
significant work has been done to characterize early HCMV promoters that has allowed 
for this model of early gene expression to be generated. This is in contrast to the limited 
number of studies that have addressed the control of expression of HCMV late genes.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
Late gene expression
True late gene expression occurs after viral DNA replication has occurred. Late 
genes primarily encode viral structural proteins, though some viral structural proteins 
such as glycoprotein B (UL55) are not expressed with true late kinetics. The UL55 
mRNA can be detected by northern analysis when viral DNA replication has been 
chemically inhibited (Smuda, Bogner, and Radsak, 1997). The late genes from HCMV 
analyzed thus far contain promoters that have a TATA box that is required for 
expression. Little sequence upstream of the TATA element is required to control 
expression in the two HCMV late gene promoters that have ben studied to date, pp28 
(UL99) (Kohler et al., 1994) and UL94 (Wing, Johnson, and Huang, 1998). The exact 
mechanism that restricts late gene expression until after DNA replication is unknown 
despite the analysis of the expression of these genes. There are three general strategies 
for this restriction of late gene expression that have been proposed. These mechanism 
are: 1) The structure of the viral DNA prior to replication blocks the activation of late 
gene expression. 2) A viral or cellular protein that is only expressed at late times of 
infection activates late gene expression. 3) A viral or cellular protein binds to late gene 
promoters and blocks activation until after viral DNA replication.
Two studies have addressed how HCMV true late gene expression is controlled. 
These studies examined UL99 (pp28) and UL94 expression. The protein product of the 
UL94 gene is a highly conserved herpes virus protein (reviewed by Mocarski, 1996).
The pp28 protein is a highly immunogenic 28 kd phosphoprotein found in the viral 
tegument (reviewed by Mocarski, 1996). Both the pp28 and UL94 promoters contain a 
TATA like element that is required for activated expression. The TATA elements of
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pp28 (TATTAA) and UL94 (TATTATTAA) do not precisely conform to consensus 
eukaryotic TATA elements (TATAA). A similar TATA is also found in the putative gH 
TATA element (TATTAAATA). Because all of these late gene TATA elements share 
loose homology with a consensus TATA, this raises the possibility that TFUD may bind 
with lower affinity. This could mean that additional proteins are required to stabilize the 
TFIED-promoter DNA interaction to allow efficient initiation of transcription.
Very little sequence is required upstream of the TATA box in each of these true 
late promoters to activate late gene expression. For example, deletion of the pp28 
promoter to -40, upstream of the TATA box (-31 to -26) activated transcription to wild 
type levels within the context of the viral genome (Kohler et al., 1994). Regulation of 
transcription of HCMV late genes is not the only method of control for HCMV late gene 
expression. Data strongly suggests that the regulation of pp28 expression is also 
posttranscriptional. This level of regulation is likely due to secondary structure in the 5’ 
leader sequence of the pp28 mRNA (Kerry et al., 1997a).
The analysis of HCMV late gene expression has been accomplished in transient 
assays as well as by generating recombinant virus. Both types of studies have been 
performed on the pp28 promoter (Depto and Stenberg, 1992; Kohler et al., 1994). This 
analysis determined that transient expression of the major immediate early genes was not 
sufficient to activate pp28 promoter expression, unlike HCMV early genes that are 
activated by the expression of the MIE genes (Depto and Stenberg, 1992). To determine 
this, a plasmid construct that expressed the MIE proteins was cotransfected with pp28 
promoter constructs. Unlike early promoters, the late pp28 promoter was not activated in 
the presence of the EE proteins in the absence of viral infection. These transient studies
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also showed that in HCMV infected cells the late pp28 promoter could be activated with 
early kinetics (Depto and Stenberg, 1992). In contrast, the promoter was activated with 
true late kinetics when reincorporated into the virus (Kohler et al., 1994). This suggests 
that recombinant viruses are more accurate in the analysis of HCMV late gene 
expression. However, because of the difficulty of generating recombinant viruses, 
transient analysis remains an effective and efficient method to identify sequence elements 
responsible for promoter activation.
Although analysis of the UL94 promoter demonstrated that sequences upstream of 
the TATA element (-38 to -30) were not required for promoter activation, these studies 
identified a role for upstream sequences in the absence of downstream sequences. The 
downstream activation domain included sequences from +1 to +48 (Wing, Johnson, and 
Huang, 1998). Sequence analysis of the UL94 promoter showed the presence of p53 and 
IE86 binding sites upstream of the TATA element between -120 and -45. These sites 
were therefore analyzed to determine their role in promoter regulation. The -120 to -45 
sequences were deleted including the p53 and IE86 binding sites and had no effect on 
activation, until these deletions were combined with deletion of sequences from +1 to 
+48. In this case, an increase in promoter activity was observed when the upstream 
repression elemente were either mutated or deleted. The binding of p53 to UL94 was 
confirmed in gel supershift assays. The authors of the UL94 study hypothesize that the 
sequences between +1 and +48 include a dominant activation domain relative to the 
upstream repression sequences between -120 to -45 (Wing, Johnson, and Huang, 1998). 
This study indicates that sequences upstream from TATA and down stream from +1 
cooperatively regulate the transcription of UL94.
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The above studies show that sequences upstream of the TATA element do not 
play a major role in transcriptional activation of HCMV late promoters. Analysis of 
herpes simplex virus (HSV) late gene promoters has demonstrated that like HCMV, 
transcriptional control elements upstream of the TATA box have limited effects on 
activation of late gene promoters. For activated transcription from HSV late promoters, a 
TATA box, an initiator element (inr) and a downstream activating sequence (DAS) are 
required (Guzowski, Singh, and Wagner, 1994; Guzowski and Wagner, 1993; Huang et 
al., 1993). The TATA box and the inr element define the boundaries of the minimal 
promoter and the DAS is required for activated transcription (Guzowski, Singh, and 
Wagner, 1994). Mutations of the inr element in the context of the HSV UL38 late 
promoter can significantly reduce or completely abrogate activity. The inr element is 
typically recognized by a TAFn-250 and TAFn-150 (TAF - TATA Binding protein 
associated Factor) complex that when bound to DNA seems to stabilize the assembly of 
the transcription initiation complex and is found in numerous eukaryotic promoters 
(Chalkley and Verrijzer, 1999). TAFs are proteins that are directly associated with the 
TATA binding protein and are components of 1F11D, an essential component of the basal 
transcription complex. TAFs interact with the basal transcription complex in a promoter 
specific manner and likely play a role in activation of gene expression (Lee and Young,
1998). The TAFs can assist in activation via protein-protein interactions or possibly by 
functioning as histone acetylases (Sterner and Berger, 2000).
The UL38 DAS core sequence (GKAGCG) is present in several other HSV late 
promoters including US 11, UL44 (gC), and UL27 (gB). Analysis of each of these 
promoters demonstrates that they share structural features in common such as a TATA
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box that is required for activation and promoter sequence downstream from the TATA 
box that is necessary to activate transcription to maximal levels (Pederson, Person, and 
Homa, 1992; Romanelli et al., 1992). This core sequence can also be found in the 
HCMV gH promoter at +1 to +6 . The DAS element is similar in function to the 
Drosophila downstream promoter element (DPE). The DPE has been shown to interact 
with T A F h60, which could in turn stabilize the transcription initiation complex. 
Interestingly, the HSV UL38 DAS has also been shown to bind either TAFn70, the 
human homolog of drosophila TAF116O or proteins that interact with TAFn70 (Wagner, 
personal communication). This suggests that similar mechanisms are regulating 
expression from promoters containing the different elements. This in turn suggests the 
importance of studying the DAS element present in the gH promoter.
Additional similarities between the HCMV gH promoter and the HSV UL38 
promoter exist. Both of these genes are expressed with true late kinetics from their 
respective genomes and both of the promoters seem to be bidirectional. The promoter for 
HSV UL38 also activates transcription of HSV UL37 in the opposite direction (Flanagan 
et al., 1991; Goodart et al., 1992). The sequence that contains the HCMV gH promoter 
also activates transcription in the opposite direction. The position of this sequence within 
the HCMV genome indicates that it should contain the promoters for both gH and UL76. 
The UL76 promoter has not been mapped and the gH promoter will be mapped in the 
experiments described in this research. Therefore, we have not yet determined if the gH 
promoter is truly bidirectional. The existence of bidirectional promoters is a fairly well 
characterized phenomenon in several viruses including Epstein-Barr virus (Nonkwelo 
and Long, 1993), Varicella-Zoster virus (Meier and Straus, 1993), and adenovirus
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(Hatfield and Hearing, 1991). Another key similarity between the HSV UL38 and 
HCMVUL75 promoters is the presence of the DAS core sequence in both promoters 
despite the different locations relative to the mRNA cap site (Guzowski, Singh, and 
Wagner, 1994). The similarities between the HSV UL38 promoter and the HCMV gH 
promoter are striking and are addressed in the research that is described in this thesis.
As mentioned earlier, there are three basic elements required for activation of the 
HSV late gene promoters described. These are the TATA, inr and DAS elements. These 
are the primary elements that have been identified in the HSV UL38 promoter, which I 
have described as very similar to the gH promoter. The primary difference between the 
HSV UL38 promoter and the HCMV gH promoter is the lack of an identifiable inr 
element. This could indicate that the promoters use slightly different mechanisms for 
activation. The current study will address any element that is important for control of 
transcription from the gH promoter.




The goal of this research is to map and characterize the promoter that is
responsible for controlling the expression of the HCMV UL75 true late gene. The
protein product of HCMV UL75 shares significant homology with glycoprotein H in
herpes simplex virus (HSV) and has therefore been designated HCMV gH (Cranage et
al., 1988; Pachl et al., 1989). This glycoprotein is important in viral host cell fusion and
in the initiation of viral gene expression. Therefore, an understanding of gH expression is
an important step in characterizing the viral replication cycle. In order to determine
specific sequences within the HCMV gH promoter responsible for regulation of gene
expression, sequences upstream of the gH open reading frame (ORF) will be assessed.
The mechanisms controlling expression of HCMV gH will be addressed in the following
experimental aims:
9
1) Determine the 5’ end of the UL75 mRNA. The determination of the location of 
the 5’ end of the mRNA is an important first step in mapping the promoter that controls 
the transcription of this essential late gene in HCMV. The knowledge of the UL75 5’ cap 
site will be important in the interpretation of the data obtained in the experiments in the 
future aims. In order to accomplish this goal, infected cell RNA was harvested and 
subjected to 5’ primer extension using a primer that is complementary to sequences 
predicted to be within 100 bases of the putative 5’ cap site. The results presented in this 
study identify the specific base where transcription initiates for the UL75 mRNA, a 
critical step in identifying and mapping the gH promoter.
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2) Sequence analysis of the gH promoter. A fragment predicted to contain the 
entire gH promoter from -453 to +35 will be analyzed using DNAsis software in order to 
determine the presence of consensus transcription factor binding sites.
3) Deletion analysis of the gH promoter. The purpose of the experiments that are 
outlined in this section is to determine regions responsible for gH promoter regulation by 
successive deletion of promoter sequence elements. Sequences from -453 to +35 
upstream of the gH ORF were previously cloned into a chloramphenicol acetyltransferase 
(CAT) expression vector (gHCAT). Deletions targeting sequences both 5’ and 3’ of the 
TATA element were generated. The activity of these mutants was assayed in transient 
transfection assays to determine promoter responsiveness to viral infection. These studies 
determined sequence elements that are important for gH promoter regulation.
4) Mutational analysis of the gH promoter. The purpose of the experiments 
outlined in this aim was to assess the role of gH promoter sequences that were 
determined by deletion analysis to be important in the control of gH promoter activation.
A series of specific mutations was generated using a PCR mutagenesis strategy. The 
effect of these mutations on promoter activity was assessed in transfection assays to 
determine promoter sequences responsible for responsiveness to viral infection. The 
results from these studies indicated specific sequences involved in controlling 
transcription.
5) Analysis of protein binding to the gH promoter. Transcription factors, both 
viral and cellular, affect transcription by either binding directly to DNA or through 
protein-protein interaction with DNA binding proteins. Gel mobility shift assays were 
therefore performed to determine protein binding to sequence elements within the gH
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promoter. Sequences within the promoter that contain transcriptional control elements 
identified in aims 3 and 4 were used as both probes and competitors. Mutations were 
generated within these sequences to determine specific elements to which proteins are 
binding. Antibodies were used in gel supershift assays to determine the specific proteins 
that are binding to the activation domains within the promoter.
The results from the experiments described above were used to generate a model 
for control of transcription by the HCMV gH promoter. Using this model and published 
data on the HCMV UL99 and UL94 late gene promoters a basic model for late gene 
expression during HCMV infection was developed.
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CHAPTER 3 
MATERIALS AND METHODS 
Primer Extension Analysis
One important aspect of mapping the HCMV gH promoter is determination of the 
precise location where transcription initiates. This was accomplished by performing 
primer extension. The procedure followed here was based on Current Protocols for 
Molecular Biology (Triezenberg, 1992). The elements required to perform this analysis 
are a primer that anneals to the target mRNA within 100 bases of the estimated end of the 
5’ mRNA cap site and the target mRNA to be mapped. The oligo used in this analysis 
gH5’primerext (GTGATCCAGGTGGTGGTTGGCGTTAC) would generate a product 
that was 77 bases according to the putative transcription start site. The initial step in the 
assay was labeling the oligo probe with 32P. The reaction contained 10 pi of y-32P ATP 
(100 pCi) (NEN, 3000 Ci/mmol), 200 ng of gH5’primerext, 2.5 pi lOx polynucleotide 
kinase (PNK from NEB) buffer, 5 units of T4 polynucleotide kinase and the volume was 
brought to 25 pi with sterile water. The labeling reaction was incubated at 37 °C for 30 
minutes and then the enzyme was heat inactivated by incubating for 5 minutes at 65 °C. 
An equal volume of 4M ammonium acetate was added in addition to 250 pi of 95% 
ethanol and the reaction was placed at —80 °C to precipitate the probe. The probe was 
was centrifuged at 14,000 rpm for 15 minutes in a refrigerated microcentrifuge 
(Eppendorf model 5412), resuspended in 25 pi of water, and the precipitation procedure 
was repeated two more times. Following the final precipitation step, the probe was 
resuspended in 100 pi of 0.3M sodium acetate and the activity of the probe was
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determined at this point by removing 1 pi and counting in a liquid scintillation counter. 
The yield of the probe in these experiments was between 100,(XX) and 200,000 cpm/pl.
The mRNA used in these experiments was harvested from mock infected and 
infected primary human fibroblasts 72 hours after infection using a Quiagen miniprep 
RNA kit exactly as described in the manufacturer’s protocol.
The probe (100,000 cpm) was then combined with 20 pg of the target RNA in 
0.3M sodium acetate and 2.5 volumes of 95% ethanol was added. The mixture was 
incubated at -80 °C to precipitate the probe and RNA. Following centrifugation, the 
pellet was air dried for 30 minutes and resuspended in 30 pi of hybridization solution 
containing 1M NaCl, 0.17 M HEPES pH 7.5 and 0.33 mM EDTA pH 8.0. The 
hybridization reaction was incubated at 30 °C for 16 hours and was then precipitated by 
adding 170 p.1 of 0.3M sodium acetate and 2.5 volumes of 95% ethanol followed by 
precipitation. The pellet containing the radiolabeled probe annealed to the target mRNA 
was washed with 75% ethanol and 25% 0.1 M sodium acetate and air dried for 30 
minutes. The samples were then ready to be treated with reverse transcriptase.
The reverse transcription reactions were prepared by resuspending the annealed mRNA 
and radiolabeled primer in 3.5 p.1 4 mM dNTP mix, 2.5 pi lOx RT buffer (0.5 M Tris pH 
8.2, 50 mM MgCh, 50 mM dithiothreitol (DTT), 0.5M KC1, 0.5mg/ml bovine serum 
albumin (BSA)), 1.25 pi of RNAsin, and brought to a volume of 25 pi with sterile 
diethylpyrocarbonate (DEPC) treated water. MMLV reverse transcriptase (200 U) 
(Superscript II Rnase H- Reverse Transcriptase, Gibco BRL) was added and the reaction 
was incubated at 42 °C for 90 minutes. The reaction was stopped by adding lpl of 0.5 M 
EDTA pH 8.0 and then incubating the reaction for 30 minutes at 37 °C after adding lp l of
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1 mg/ml of Rnase A. To stop this reaction, 100 p.1 of 2.5M ammonium acetate was added 
and the mixture was extracted using phenol:chloroform using a standard protocol as per 
Current Protocols for Molecular Biology (Moore, 1992). After extraction, 300 pi of 95% 
ethanol was added and the product was precipitated. The pellet was washed with 70% 
ethanol, dried in a Sorvall Speed Vacuum Concentrator, and resuspended in 4 pi of water. 
An equal volume of loading dye (Pharmacia) was added to the resuspended product and 
boiled for three minutes, then placed on ice. Half of the product was then loaded on to a 
12.5% sequencing gel (12.5% acrylamide, 0.5% bis-acrylamide, 42% urea, 7.5 ml lOx 
TBE (900 mM Tris, 900 mM boric acid, and 25 mM EDTA, pH 8.0 - 8.5), 39.5 ml sterile 
water) and electrophoresed in IxTBE. After electrophoresis, the gel was exposed to x- 
ray film at -80 °C in the presence of an intensifying screen.
Cloning Procedures 
Restriction Digests
All restriction enzyme digests described in these studies unless otherwise noted, 
were carried out using restriction enzymes from New England Biolabs (NEB) with 
company buffers and following manufacture’s instructions. For most digests, 3-5 units of 
enzyme were used per pg of DNA digested and the reaction was incubated for 
approximately 2 hours at the appropriate temperature.
Ligation Reactions
All ligation reactions were performed using 20 units of ligase (NEB) and buffer 
provided by the manufacturer in a reaction volume of 20 pi. All ligation reactions were 
performed with 100-300 ng of vector DNA and three to five molar excess of insert when 
necessary. The ligation reactions were incubated at 16 °C for at least 16 hours.
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Phosphatase Reactions
These reactions were performed on restriction digest products that require that the 
5’ phosphate to be removed. This includes vector DNA that could self ligate or 
fragments that will be radiolabeled with 32P. 1 to 2 pi of calf intestinal phosphatase (20 
U/pl) (Boehringer Mannheim) was added to the target digest reaction in addition to the 
manufacturer’s lOx phosphatase buffer and the reaction was diluted so that the 
phosphatase buffer was at a Ix concentration. The reaction was incubated at 37 °C for 30 
minutes, 1 to 2 more pi of phosphatase was added, and the reaction was incubated for an 
additional 30 minutes. The products were then purified on an acrylamide gel.
Generation of Competent Bacteria
Competent E. coli (XL-1 blue strain) were generated by culturing cells taken from 
a glycerol stock in 5 ml of LB media (0.5 % yeast extract, 1 % tryptone, 0.5 % NaCl, and 
0.5 ml of IN NaOH) overnight with vigorous shaking at 37 °C. This culture was then 
added to a 250 ml LB culture and grown by shaking at 37 °C to an absorbance of 0.4 to 
0.5 at 550 nm. The culture was then rapidly cooled to 0 °C, centrifuged in a sterile 500 
ml tube for 15 minutes at 5000 rpm at 4 °C in a Beckman JA-10 rotor to pellet the cells 
and resuspended in 100 mM CaC^. The cells were incubated on ice for 30 minutes and 
repelleted by centrifugation in a Beckman JA-12 rotor at 6000 rpm for 20 minutes at 4 °C. 
Next the cells were resuspended in 100 mM CaCh containing 15% glycerol and aliquoted 
into prechilled sterile eppendorf tubes and incubated at 0 °C for 16 hours. These aliquots 
were then frozen at in a dry ice bath and subsequently stored at -80 °C.
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Transformation of Bacteria
Plasmids were transformed into competent bacteria using a heat shock method. 
Either 100 ng of purified plasmid or a 10 p.1 portion of a ligation reaction was mixed with 
100 p.1 of competent E. coli and incubated on ice for 30 minutes. This reaction was then 
incubated at 42 °C for 2 minutes then allowed to recover on ice for 5 minutes. The 
transformation reaction was then transferred into 1ml of LB and shaken at 37 C° for 
60-90 minutes. A 200 pi aliquot of this culture was plated onto a LB agar plate 
containing 100 pg/ml of ampicillin. Colonies from the plate were picked and grown up 
in 5 ml cultures.
Miniprep Analysis of Plasmid Constructs
In order to screen for the generation of desired constructs, an alkaline lysis 
miniprep procedure was performed (Bimboim and Doly, 1979). Individual colonies were 
used to inoculate a 5 ml culture containing ampicillin (100 pg/ml). After a 16 hour 
incubation at 37 °C in a shaking incubator, 1.5 ml of this culture was transferred to a 
microfuge tube and the cells were pelleted and the media was aspirated. The pellet was 
resuspended in 100 pi of buffer containing 50mM Tris pH 8.0, 8% sucrose, lOmM 
EDTA, and 5 mg/ml of lysozyme. To this suspension, 200 pi of a buffer containing 0.2N 
NaOH and 1% SDS was added, mixed by inversion and incubated for 5 minutes at room 
temperature. At this time a solution of 1.8 M potassium acetate and 11.5% (v/v) glacial 
acetic acid was added, mixed by inversion, and incubated on ice for 5 minutes. The 
sample was centrifuged for 5 minutes at 12,000 rpm in an Eppendorf microcentrifuge at 
room temperature to remove the cellular debris. The supernatant was transferred to 
another tube and 1 volume of isopropanol (approx. 450 pi) was added to precipitate the
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plasmid DNA. After a 15 minute incubation at room temperature, the mixture was 
centrifuged at 12,000 rpm to precipitate the plasmid DNA. The pelleted DNA was 
washed with 70% ethanol, dried, and resuspended in 50 pi of water.
For digestion of miniprep DNA, 5 ml was digested in the presence of 2 pg of 
Rnase A per reaction and 5 pi of miniprep DNA. Reactions were stopped with stop dye 
(50% glycerol, lOOmM EDTA, 0.1% bromophenol blue, pH 8.0), loaded and run on a 
0.8% to 1.2% TBE agarose gel, stained with 0.0004% ethidium bromide, and visualized 
with a 312 nm UV transilluminator.
Some of the clones generated for these studies required purified DNA suitable for 
sequencing. To generate this DNA, the entire 5ml culture was pelleted in a microfuge 
tube and the plasmid DNA isolated using Quiagen miniprep columns according to 
manufacturer’s instructions. This DNA was quantitated by determining the absorbance at 
260nm with a Beckman spectrophotometer and 4-8 pg was used in sequencing reactions. 
DNA Sequencing
All of the plasmid constructs were sequenced to determine that all deletions and 
mutations were generated accurately. The protocol used to sequence these clones utilized 
a modification of the dideoxy sequencing method (Sanger, Nicklen, and Coulson, 1977). 
The modifications were necessary because the sequencing reactions were run in an ALF 
automated DNA sequencer (Pharmacia). The reactions were labeled with flourescein 
instead of 32P.
The reaction were run using an Autoread Sequencing Kit (Pharmacia) and 
following a protocol provided by the manufacturer. The reactions were run using 4-8 pg 
of plasmid DNA and 5 pmoles of primer. The AD-1 primer
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(TCAACGGTGGTATATCCAGT) was generated labeled with flourescein (FAD-1) and 
unlabeled. The protocol used was slightly different depending on the primer. When the 
unlabeled primer was used, the reaction product was labeled with flourescein-dATP 
according to the manufacture’s protocol. When sequence reads of under 200 bp were 
required, the protocol utilizing the FAD-1 primer was performed and when longer reads 
were required the protocol using the unlabeled primer was performed.
Large Scale Plasmid Purification
Large stocks of plasmid DNA were generated using Quiagen columns. Briefly, 
an overnight culture of 3 to 5 ml was generated as described for the miniprep cultures. 
This culture was then used to inoculate a 250 ml culture of LB media containing 100 
pg/ml of ampicillin. This culture was grown for 4 to 6 hours at 37 °C in a shaking 
incubator and then amplified with 170 pg of chlroamphenicol per ml of culture. The 
culture was incubated for 16 hours in the presence of the chloramphenicol, and then 
transferred into a 500 ml centrifuge bottle and the bacteria were pelleted by centrifuging 
the culture at 5000 rpm in a Beckman JA-10 rotor. The plasmid DNA was then purified 
using a Quiagen maxiprep column following the protocol provided by the manufacturer 
in the product literature.
Isolation of DNA Fragments
In order to isolate a DNA fragment from a reaction containing more than one 
product, the reactions were stopped with stop dye (50% glycerol, lOOmM EDTA, 0.1% 
bromophenol blue) and loaded onto a 5 % acrylamide IX TBE (90 mM Tris, 90 mM 
boric acid, and 2.5 mM EDTA, pH 8.0 - 8.5) gel. The gels were made either 1.5 or 3 mm 
thick. The thin gels were 15 cm in length and the thick gels were 30 cm in length- The
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thick gels were run at 16 to 20 mA for 16 hours and the short gels were run for about 2 
hours at 30 to 40 mA. DNA fragments for cloning were isolated by electroelution from 
these acrylamide gels. In order to visualize the DNA, the gel was soaked in 0.0004% 
ethidium bromide and examined on a UV light box. The gel region containing the 
appropriate DNA fragment was excised from the gel and then placed in dialysis tubing 
with 0.5 ml of 0.05X TBE (4.5 mM tris, 4.5 mM boric acid, and 125 pM EDTA, pH 8.0 - 
8.5) and clamped at both ends. A 12 mA current was run through the dialysis bag and gel 
fragment for 2 hours. This solution containing the DNA was transferred from the dialysis 
bag to a 1.8 ml Eppendorf tube and the DNA was precipitated by adding 0.1 volume of 
5M NaCl and 2 volumes of absolute ethanol and incubating at —20 °C overnight. The 
DNA was then pelleted by spinning the solution in a refrigerated microcentrifuge at 4 °C 
at 14,000 rpm for 15 minutes and washing the DNA in 70% ethanol and spinning for 5 
minutes. The pellet was then dried and resuspended in an appropriate volume of sterile 
water.
Annealing of Oligonucleotides
There are several assays described in this dissertation that require double stranded 
oligonucleotide (oligo) fragments including the generation of sequence mutants and 
generation of fragments for DNA binding assays. To generate the fragments, 10 pg of 
each of the complementary oligos was mixed with buffer containing 100 mM NaCl, 2mM 
MgCb, 20 mM Tris in a microfuge tube. This mixture was heated to 80 °C and incubated 
for 10 minutes. The mixture was then slowly cooled to room temperature to allow proper 
annealing of the oligos. The room temperature annealing reaction was then extracted 
with one volume of phenol saturated with TE followed by extraction with chloroform.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
36
The resulting supernatant containing the annealed fragment was then precipitated in the 
presence of 200 mM NaCl, washed with 70% ethanol and resuspended in 100 pi of sterile 
water. This created DNA stocks containing approximately 200 ng/pl of the annealed 
oligo fragment, which were used in gel shift analysis or in cloning procedures. 
Construction of gH Deletions to -245 and -117
The original gH promoter chloramphenicol acetyl transferase (CAT) construct 
(gHCAT) has been described previously (Depto, 1991). All of the gHCAT constructs are 
based on this construct which contained the 488 base pair (bp) Bam HI to PstI gH 
promoter fragment cloned into a CAT reporter vector (pSVoCAT) which contains a Hind 
ELI site immediately upstream from the CAT open reading frame. An intermediate 
construct (pUCHHgH) described previously (Depto, 1991) was used to generate two of 
the deletion mutants contained genomic sequences from 110208 (Bam HI) to 110694 
(PstI) gH promoter fragment (figure 2) cloned into a modified pUC12 vector (pUCHH) 
with a Hind HI site at each end of the multiple cloning site (mcs).
The first constructs generated deleted gH promoter sequence from —453 to -245 
and —453 to —117. To generate these deletions restriction enzyme digest was performed 
using Pst I and either Stu I (-245) or Bst BI (-117) (figure 3). 5pg of pUCHHgH plasmid 
was digested with each of these pairs of enzymes to remove the appropriate fragment of 
the promoter. After digestion, these reactions were treated with the Klenow fragment of 
DNA polymerase I to generate blunt ends as per manufacturer’s instructions (30 minute 
incubation at room temperature). The vector fragment with the remaining promoter was 
then gel purified. A 2 pL aliquot of the 25 pi DNA suspension (100-200 ng) was
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removed and placed in a ligation, and 10 pi of this reaction was transformed into
competent XL-1 blue E. coli as previously described.
UL75 UL76




FIG 2. Graphic representation of the gH promoter. The top of the figure is a linear 
representation of the HCMV genome. The sequence that contains the gH promoter 
also drives the expression of UL76 which is expressed from the opposite strand in the 
opposite direction. The original gHCAT construct contains sequences from the UL76 
ORF. The bold numbers indicate the exact sequence location according to the 
published AD 169 sequence and the italicized numbers are the gH promoter 
coordinates according to the UL75 5’ mRNA cap site.
After the intramolecular ligation reaction of the pUCHHgH deletion mutants, the 
promoter fragment was cloned into the Hind HI site in pSVoCAT. This was 
accomplished by first digesting 5 pg of each of the pUCHHgH deletion mutants with 
Hind EH and gel purifying the gH promoter fragment. The promoter fragment was then 
ligated into 100 ng of pSVoCAT that had been digested with Hind HI and treated with 
alkaline phosphatase as previously described.




Digest with PstI and either BstBI 








Digest with Hind III 
and clone fragment 
into pSVOCAT
CAT genegHCAT245
FIG 3. Cloning strategy used to generate gHCAT deletion constructs. The 
pUCHHgH plasmid is represented at the top of the figure. The restriction enzyme 
sites present are indicated: H=Hind III, E=Eco R I, Ss=Sst I, S=Sma I, B=Bam H I, 
P=Pst I, St=Stu I. The pUCHHgH digested with Stu I vector fragment is indicated on 
the left and the ligated product of this reaction is indicated on the right. The -245 to 
+35 promoter fragment cloned into pSVoCAT (gHCAT245) is indicated at the bottom 
of the figure.
Deletion of gH promoter sequences from +15 to +35
An additional deletion of sequences from +15 to +35 in several of the mutant 
constructs was made. To accomplish this we utilized a Sma I site that cuts at +14 in the
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gH promoter and a Sma I site in the vector that overlaps the BamH I site at the 3’ end of 
the promoter (figure 3). Therefore, digestion with Sma I effectively eliminates the 
sequences between these two sites. This was achieved by digesting 2 pg of the target 
plasmid with Sma I, phenol-chloroform extracting the reaction and then religating the 
ends of the vector.
PCR Mutagenesis to Generate Deletions and Mutations
Further deletion and mutation of gH promoter sequence was necessary to 
completely analyze promoter function. Due to a lack of convenient restriction enzyme 
sites, additional deletions were generated using a PCR mutagenesis strategy (figure 4)
PCR mutagenesis was used to generate Hind III sites at -81 and -38 in the gH promoter 
in the gHCATl 17 vector. The Hind m  sites that were generated in addition to the Hind 
in site at the 3’ end of the gHCAT promoter fragment were then used to clone the 
truncated gH promoter fragment into pSVoCAT. The same PCR mutagenesis strategy 
was used to generate most of the sequence mutants that will be described in this 
dissertation. A two step PCR process was used. For this method, four primers are 
required, two external primers that anneal to sequences outside of the region that will be 
mutated and two complementary oligonucleotides (oligos) that contain the desired 
mutations. The external primers annealed to pSVoCAT vector sequences, one primer 
from the CAT gene (3’dd) and the other contained sequences on the opposite side of the 
Hind HI site used to clone the promoter fragment (5’aa).
The first mutant generated a Hind HI site at -81 in the gH promoter. The primers 
that were used to generate this specific mutation as well as all primers that were used in 
PCR mutagenesis are shown in table 1. The first set of PCR reactions were started with
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10 ng of gHCAT. In addition, each reaction contained 20 pmol of a forward or reverse 
mutant primer (table 1) and the forward 5’dd or reverse 3’dd external primer (table 1),
2pL of lOmM dNTP mix, 3(il of MgCb, 0.5 (J.1 Platinum Taq DNA polymerase (Gibco 
BRL), and lOp.1 of the manufacturer’s PCR buffer. The reaction was brought to a volume 













FIG 4. The PCR mutagenesis strategy, (i) A schematic representation of the promoter 
fragment present in gHCAT, the construct that was used as the vector for generation of 
the deletion mutants, (ii) The primers that were used to generate the mutations, the 
forward mutant primer was always mixed with the 3’dd external primer and the reverse 
mutant primer was always mixed with the 5’aa external primer. (iii) The reaction 
products from each of these reactions, (iv) The reaction product that is generated when 
the two previous products are combined in a reaction to generate the final product that 
contains the desired mutation. In this example the resulting fragment is digested with 
Hind ED and cloned into pSVoCAT. P-Pst I site, B-BamH I site, X-location of the 
Hindm site to be generated in the mutagenisis.
The reaction was placed in a Techne thermalcycler programmed to run the 
following cycles: 1 cycle for 2 minutes at 94 °C, 30 cycles for 1 minute at 93 °C, 1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
41
minute at 56 °C, 2 minutes at 72 °C. The products of the PCR reactions (10 pi) were run 
on 1% agarose gels and visualized by staining with ethidium bromide. Once the presence 
of the correct PCR products was confirmed on the gel, the products to be used in the 
second stage PCR reactions were treated with KJenow polymerase. This reaction was 
performed by mixing 7 pi of each PCR product with 1ml dNTPs, 1 U Klenow, and lp l of 
NEbuffer 2 (NEB) and incubating at room temperature for 30 minutes.
A 1 pi aliquot of these Klenow reactions was put into the second stage PCR 
reaction. The reaction also contained 20 pmols of 3’dd and 5’aa primers, 2pl of lOmM 
dNTP mix, 3pl of MgCh, 0.5 pi Platinum Taq DNA polymerase, and lOpl of the 
manufacturer’s PCR buffer. This reaction mix was brought to a volume of 100 pi, placed 
in a thin walled PCR tube and incubated identically to the first set of PCR reactions. The 
product from this reaction was run on a 1% agarose. Once the presence of a sufficient 
product was confirmed on the gel, 50 pi of the PCR reaction product was digested with 
Hind HI and run on a 5% TBE acrylamide gel. The digested product was isolated and 
electroeluted from the gel and subsequently ligated into pSVoCAT vector as previously 
described.
Generation of WX and PX Mutations
Mutations were generated within the the PEA3 and W-elements by taking 
advantage of the Sma I sites present at +14 and overlapping the 3’ end of the promoter 
(figure 3). Digestion with the Sma I restriction enzyme leaves a blunt end, which can be 
difficult to clone. An isoschizomer of Sma I is Xma I that leaves a 5’ extension on the 
digested products that make cloning into an Xma I site easier. An Xma I digest was 
therefore performed on 5 pg of gHCAT and this product was phosphatase treated as
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
42
previously described. A 200 ng aliquot of this vector DNA was placed in a ligation 
reaction with 5 ng of the annealed WX or PX oligo fragment (table 2).
Table 1
PCR primers used to generate m utations
Title Sequence (S’ to 3’) Constructs generated
UL75 Hind HI fwd CCCTTCGCAGCGGCCAAGCTTATCGT 
ATT AAAT AG ACG
gHCAT38
UL75 Hind EH rev CGTCTATTTAATACGATAAGCTTGGC
CGCTGCGAAGGG
gHl 16 forward GCAAAGCTTACTCGCGTGTCCCCTCTT
CTC gHCAT81
gHl 16re verse G AG A AG AGGGG AC ACGCGAGT AAG 
CTTTGC
gHCAT 12fwd GT A ACCCGT AG AT ATCC ACCCGGG
gHCAT38m2
gHCAT 12rev CCCGGGTGG AT ATCT ACGGGTTAC
gHCAT24fwd G ACGCG ACTTTTGGT ATACGT AGCG
gHCAT38ml2
gHCAT24rev CGCTACGTATACCAAAAGTCGCGTC
gHCAT26fwd GAG ACGCG ATCG ATT AACCCGT AGC gHCAT38ml7,
gHCAT26rev GCTACGGGTTAATCGATCGCGTCTC gHCATml7PX
gHCAT30fwd G ACGGTCTAGAG ACTTTTGT AACCCG gHCAT38m25,
gHCAT30rev CGGGTTACAAAAGTCTCTAGACCGTC gHCAT38m25PX
gHCAT41fwd CGT ATT AAAT ACT AGT AGACGCG AC gHCAT38m30,
gHCAT41rev GTCGCGTCTACTAGT ATTTAAT ACG gHCAT38m30PX
gHDASforward GT AACCCGT AAT A ACGC ACCCG gHCATDAS,
gHDASreverse CGGGTGCGTT ATT ACGGGTTAC gHCAT38DAS
3’dd CC AGCTG AACGGTCTGGTT AT AGG all
5’aa GC ATCTGTGCGGT ATTTC AC ACCG all
* Bold text indicates bases that are mutated compared to wt promoter sequence. The 
mutations that each pair of oligos created, generated restriction enzyme sites as follows: 
UL75 Hind III -  Hind III, gHl 16 -  Hind III, gHCAT41 -  Spe I, gHCAT30 -  Xba I, 
gHCAT26 -  Cla I, gHCAT24 -  Acc I, gHCAT12 -  EcoR V.
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The mutations generated a novel Xba I site, so this enzyme was used to screen 
minipreps generated from these ligations. Several constructs that contained the Xba I site 
were then grown up and purified with a Quiagen miniprep column and sequenced to 
confirm the presence of a single insert. The appropriate mutant constructs were then 
grown up in large cultures and purified as previously described.
Table 2
Oligonucleotides used to generate WX and PX mutations
Title Sequence (5’ to 3’)




* Bold text indicates bases that are mutated compared to wt promoter sequence.
Cell Culture
The cells used in all of the experiments described in this dissertation are primary 
human fibroblasts harvested from pooled human foreskins removed shortly after birth 
(HFF). The cells were grown in minimal essential media (Gibco BRL) supplemented 
with 10 % newborn calf serum (Gibco BRL). Cells were incubated at 37 °C and 5% CO2 
in T-150 tissue culture flasks (Coming) and split weekly when used for transfection.
Cells were split by treating them with trypsin (.05%) and incubating for 15 to 20 minutes 
at 37 °C. The cells were then resuspended in complete cell culture media and split into 
two T-150 flasks. When not needed for experiments, the cells were split every two to 
three weeks. These cells were split weekly at least two weeks prior to being used in 
transfection.
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Virus Culture
All of the experiments performed in the studies described in this dissertation used 
the Towne strain of HCMV unless otherwise noted. The virus cultures were grown in 
primary human fibroblasts. The virus cultures were started by diluting a high titer stock 
(approximately 108 pfu/ml) 1 to 10,000 in complete cell culture media and infecting each 
T-150 flask of cells with 10 ml of this dilute virus solution for 2 hours at 37 °C. The 
culture was removed and replaced with 35 ml of media. The media was changed every 4 
to 5 days and the cells were observed for cytopathic effect (cpe). When 100% of the cells 
exhibited signs of cpe, the media was changed for the last time and the cells were 
incubated for 4 more days. The total incubation time was approximately 12-15 days. To 
harvest the virus, any cells adhering to the flask were dislodged by agitation, all of the 
culture supernatants were combined into one flask and the media containing the 
infectious virus was aliquoted into cryovials. The cryovials were snap frozen in a dry ice 
bath and stored at -80  °C.
Plaque Assay
Each virus culture was quantitated by plaque assay, using confluent HFFs grown 
on 60 mm plates. Serial dilutions of infectious virus culture were generated in duplicate 
from 10'1 to 10’8. Each plate was infected with 1ml of the appropriate dilution and 
incubated for 2 hours at 37 °C. The virus culture was removed and replaced with 4 ml of 
cell culture media. After overnight incubation, the cell culture media were removed and 
the cells were overlayed with 4 ml of 2x minimal essential media supplemented with 10% 
fetal bovine serum (Gibco BRL) and diluted to a lx concentration with agarose at a final 
concentration of 0.5%. These cultures were incubated for four days and the overlay
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process was repeated. After 7 days the plaques were counted. The amount of infectious 
virus was determined by counting the individual plaques duplicate plates. This number 
along with the dilution was used to determine the plaque forming units (pfu) per ml. 
Transfection -  superinfection
In order to determine the promoter activity of each of the gH promoter-CAT 
constructs, a transfection using DEAE dextran followed by infection with the Towne 
strain of HCMV was performed. The transfections were carried out in primary human 
fibroblasts that were grown as described in the cell culture section of this chapter. Cells 
were split into T-150 flasks, incubated for 72 hours at 37 °C and split on to 12 x 60 mm 
plates per flask. These cells were grown for 24 hours to 80-90% confluence in the plates 
before transfection. For transfection the cells were first washed with Tris buffered saline 
(TBS) (30 mM Tris pH 7.2, 150mM NaCl) followed by application of 400 pi of 
DNA/DEAE dextran solution (4 pg of plasmid DNA and 0.5 mg/ml of DEAE dextran in 
TBS) to the cells. This solution was incubated on the cells at 37 °C for 30 minutes, 
rocking the cells every 5 minutes. The cells were then overlaid with completed minimal 
essential cell culture media containing 100 pM chloroquine. After a 3 hour incubation at 
37 °C the media containing chloroquine were removed, the cells were washed twice with 
TBS and overlaid with 4 ml of fresh media. The now transfected cells were incubated for 
18 hours at 37 °C to recover from the transfection. Following the recovery period the 
cells were infected with the Towne strain of HCMV. The virus stock was diluted in cell 
culture media and used to infect at 10 pfu/cell. A volume of 1 ml of this diluted virus 
was overlayed on the transfected cells and incubated for 2 hours at 37 °C to allow the 
virus to adsorb. Following infection the vims was removed and replaced with 4 ml of
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fresh cell culture media. The cells were incubated for 72 hours following infection and 
harvested.
The cells were harvested to generate chloramphenicol acetyl transferase (CAT) 
extracts that would be used to evaluate promoter activity, by first washing with TBS, 
followed by scraping the cells off of the plate into 1 ml of TBS and transferring into a 
microfuge tube. The cells were pelleted by centrifugation in an Eppendorf 
microcentrifuge for 10 minutes at 4,000 rpm. The cell pellet was resuspended in 50 pL 
of 0.25 M Tris pH 7.8 and subsequently frozen in a dry ice/ethanol bath. The cells could 
be stored at this point or lysed by freezing and thawing. For the freeze/thaw procedure 
the cells were first incubated for 5 minutes in a dry ice/ethanol bath followed by a 5 
minute incubation at 37 °C. This cycle was repeated three times to insure that the cells 
were completely lysed. To remove the cellular debris generated from the freeze/thaw, the 
extracts were centrifuged in an Eppendorf microcentrifuge for 5 minutes at 12000 rpm 
and the supernatant was transferred to a fresh microfuge tube and then incubated at 68 °C 
for 10 minutes to inactivate any cellular proteases that may be present. These CAT 
extracts were stored at -80 °C.
CAT Assay
In order to evaluate the activity of the promoter-CAT constructs after 
transfection-superinfection, a CAT assay was performed. Each of the standard CAT 
assay reactions contained 20 pi of 4mM acetyl Co-A, 70 pi of 0.25 M Tris pH 7.8, 0.2 
pCi of 14C-Chloramphenicol (56.2 mCi/mmol) and the volume was brought to 125 pi 
with sterile water. To begin the assay, 20 pi of CAT extract was added to the reaction, 
vortexed, and incubated at 37 °C for 30 minutes. The reaction was stopped with the
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addition of 750pl ethyl acetate followed by 30 seconds of vigorous vortexing. The 
reaction was then centrifuged at 12,000 rpm in in an Eppendorf microcentrifuge to 
separate the aqueous phase from the ethyl acetate. The ethyl acetate was extracted with a 
pipette tip, transferred to a new microfuge tube and dried under vacuum in a Sorvall 
Speed Vacuum Concentrator. The reaction products were then resuspended in 20 pi of 
ethyl acetate and spotted onto a silica gel thin layer chromatography plate. The reaction 
products were separated in a thin layer chromatography chamber using a mobile phase 
containing 19:1 chloroform:methanol (v/v). After separation of the reaction products, the 
plate was subjected to autoradiography to get a visual representation of the CAT assay 
and the reaction products were quantitated using a Molecular Dynamics Phosphorimager. 
To correct for experimental variability some of the transfection experiments were 
normalized according to protein concentration. This was done by quantitating the protein 
using Bradford reagent (Bio-rad) according to the manufacturer’s instructions and 
comparing to a standard curve generated using BSA as a standard on a Beckman 
spectrophotometer.
Generation of Nuclear Extracts
In order to assess protein-DNA interactions, nuclear extracts were generated using 
a procedure modified from that of Dignam (Dignam et al., 1983). The nuclear extracts 
were isolated from fibroblasts that were either mock infected or infected with 10 pfu/cell 
of the Towne strain of HCMV. After 72 hours the cells were washed twice with TBS and 
harvested into buffer A containing 10 mM HEPES pH 7.9, 1.5 mM MgCh, 0.5% NP-40, 
0.5 pM DTT, 2 pg/ml aprotinin, 2.5 p.g/ml leupeptin, 1 pg/ml pepstatin and ImM PMSF 
(phenylmethylsulfonylfluoride). Five 100 mm cell culture dishes were harvested into 1
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ml of this buffer. Once harvested, the cells were placed into a sterile prechilled 15 ml 
centrifuge tube and placed on ice. The cells were then lysed by gently pipetting up and 
down for 10 minutes. The nuclei were isolated by centrifuging at 2000 rpm for 10 
minutes in a Sorvall refrigerated table top centrifuge (model RTB-6000) at 4 °C and 
resuspended in 1 ml of buffer C per 15 plates (20 mM HEPES pH 7.9, 25% glycerol 
(v/v), 1.5 mM MgCb, 0.42 M NaCl, 0.2 mM EDTA, 0.5 mM DTT, 2 pg/ml aprotinin, 2.5 
pg/ml leupeptin, 1 pg/ml pepstatin and ImM PMSF). The pellet was then resuspended 
on ice, mixing every 5 minutes for a total of 30 minutes. The cellular debris was then 
removed from this suspension by centrifugation at 14,000 rpm in a refrigerated 
microcentrifuge for 30 minutes at 4 °C. The supernatant is then transferred from the 
microfuge tube to dialysis tubing (Spectrapor, 6000-8000) and dialyzed against buffer D 
(20 mM HEPES pH 7.9, 20% glycerol (v/v), 100 mM KC1, 0.2 mM EDTA, 0.5 mM DTT 
and 0.5 mM PMSF) for five hours. The extract was then aliquoted into pre-chilled 
microfuge tubes, frozen in a dry ice/ethanol bath, and stored at -80 °C. The protein 
concentration was determined using a protein assay (Bio-rad) and compared to BS A 
standards on a Beckman spectrophotometer.
Specific extracts were generated to test protein binding at at early times of viral 
infection. To generate these extracts two different methods were employed. The first 
method was identical to the method above except that the cells were infected with Towne 
HCMV in the presence of phosphonoacetic acid (PAA, 200 pg/ml), a chemical that 
specifically inhibits viral DNA replication and thus restricts viral gene expression to the 
IE and E phases. An alternate method used to generate nuclear extracts restricted to the 
early phase of replication requires a temperature sensitive mutant of HCMV called ts66.
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When grown at 34 °C, the infection progresses as normal, but when the virus is cultured 
at 39 °C DNA replication is blocked and gene expression is restricted to the early phase 
of replication. Cells were infected with ts66 at 10 pfu/cell and grown at 34 °C to generate 
late extracts and 39 °C to generate extracts restricted to early gene expression. The 
extracts were generated using the same protocol described above.
Gel Shift Analysis
In order to determine protein binding to promoter sequences, gel shift analysis 
was performed. This analysis requires DNA binding proteins, provided by the nuclear 
extracts generated in the previous section, and a 32P labeled probe to test protein binding. 
For the first set of experiments, a 152 bp (base pair) probe was generated by digesting 
100 pg of gHCATl 17 with Hind HI and BamH I. The digested product was treated with 
phosphatase and gel purified as previously described. This digest produced 
approximately 3 pg of product that was resuspended in 100 pL of sterile water. A 5 pi 
aliquot was removed and labeled with 32P. The labeling reaction contained 5 pi of probe 
DNA (150 ng), 2 pi of lOx kinase buffer (NEB), 7 pi of sterile water, 1 pi of T4 
polynucleotide kinase (NEB) and 5 pi (50 pCi) of y-32P ATP (NEN, 3000 Ci/mmol).
This reaction mix was incubated for 30 minutes at 37 °C. The labeled probe DNA was 
then purified on a NucTrap push column (Strategene) according to manufacturer’s 
instructions and resulted in a final volume of 120 pi containing approximately Ing/pl of 
probe DNA. The incorporated radioactivity was determined by counting 1 pi of probe in 
a liquid scintillation counter (Beckman). The activity of the probe DNA was generally 
between 20,000 and 50,000 cpm per ng.
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The binding reactions using the 152 bp probe all contained 50,000 cpm of probe 
DNA, 10 pi of nuclear extract and 5 pg of poly dldC. Some of the reactions also 
contained either a specific or nonspecific competitor at a 100 fold molar excess. The 
nuclear extracts were preincubated with the dldC and competitors for 15 minutes at room 
temperature, the probe was added and the binding reactions were incubated for 20 
additional minutes. The reactions were then loaded on a 4% 0.5x TBE nondenaturing 
polyacrylamide gel. After electrophoresis at 20 mA of constant current, the gel was dried 
on a Sorvall gel drier and exposed to X-ray film to visualize the bands.
In addition, oligonucleotide fragments were used as probe DNA. The oligos used 
to generate these fragments are shown in table 3. The oligos were annealed as described 
previously and the fragments were labeled. Once the fragments were labeled, 4 pi of 
glycerol was added to the reaction and it was loaded on to a 5% acrylamide gel, purified 
and electroeluted as previously described. These oligo fragments were also used as 
competitors in some of the assays at up to 300 fold molar excess. The gel shifts using the 
35 bp GWP probe (table 3) were run on 4% 0.5x TBE nondenaturing polyacrylamide gel 
as above. The gel shifts performed using the shorter probes such as the PEA3wt probe 
were run on 4% 0.25x TBE nondenaturing polyacrylamide gels. The gel shifts using 
these short oligo probes also contained only 0.2 mg of poly dldC per reaction. The 
conditions were otherwise identical.
To attempt to identify specific proteins binding promoter sequences gel supershift 
analysis was performed. For supershift analysis, an antibody is added to the binding 
reactions described earlier and if the antibody binds to a protein that is binding to 
promoter sequences. The band generated by this protein should be partially or completely
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shifted upward. In this analysis, antibodies to PEA3 and Etsl and 2 (Santa Cruz 
Biochemical) were used. The PEA3 antibody was a mouse monoclonal that is specific for 
the pea3 protein. The Etsl and 2 antibody is cross reactive with these proteins as well as 
other members of the ets family of transcription factors, although the manufacturer did 
not specify which ones. The antibodies were added at different points in the binding 
reaction as well as in different concentrations.
Table 3
Oligonucleotides used to generate fragments for probes and competitors in gel
shift analysis
Title Sequence (5’to 3’)
GWPfwd GTAGCGCCGCACCCGGGTGCTCCTTCCTGGGATCC
GWPrev GG ATCCC AGG A AGG AGC ACCCGGGT GCGGCGCT AC
PEA3wtfwd GGTGCTCCTTCCTGGGATCC
PEA3wtrev GGATCCCAGGAAGGAGCACC
PEA3PXfwd GGTGCTCTCT AG AGGG ATCC
PEA3PXrev GGATCCCTCTAGAGAGCACC
gHC ATD AS wtfwd GT AACCCGTAGCGCCGCACCCG
gHCATDASwtrev CGGGTGCGGCGCT ACGGGTT AC
gHDASforward GTAACCCGTAATAACGCACCCG
gHDASreverse CGGGTGCGTT ATT ACGGGTTAC
gH-117to-81fwd CGAATCAGCGTCGTCCCCACACCCGGACGGCATGACT
gH-117to-81rev AGTCATGCCGTCCGGGTGTGGGGACGACGCTGATTCG






* Bold text indicates bases that are mutated compared to wt promoter sequence.
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In these assays, all of the reagents described above were added to the binding 
reaction and incubated for 15 minutes. The probe was then added and incubated for 20 
minutes as described above, followed by the addition of 0.2, 0.4 and 0.8 p.g of antibody to 
different reaction tubes. Alternatively, the antibody was added to the binding reaction 
before the addition of the probe assess for the ability to block DNA binding.





The purpose of the experiments outlined in this chapter is to map and characterize 
the functional regions of the HCMV UL75 late gene promoter. The protein product of 
the HCMV UL75 gene is glycoprotein H (gH). This glycoprotein is involved in 
attachment and penetration of host cells. In addition, binding of gH to host cells activates 
the expression of cellular transcription factors that are involved in the initiation of viral 
gene expression (Yurochko et al., 1997). The importance of gH in the initial stages of 
infection makes this protein important in the overall pathogenesis of HCMV infection. 
Understanding the control of the expression of this critical envelope glycoprotein will 
therefore provide information about virus host interactions important for the replication 
of HCMV.
The experiments in this study will define the promoter by first mapping the 
mRNA cap site, identifying regions of sequence responsible for transcriptional control, 
and then characterizing specific sequence elements within the promoter that are 
responsible for control of expression.
Determine the 5’ end of the UL75 mRNA.
The putative location of the UL75 mRNA cap site was previously determined 
(Depto, 1991) based on the location of the TATA box (-34 to -26) that is present in the 
promoter. However, there was no experimental evidence to confirm the actual location 
of the cap site. In order to completely map the sequences responsible for the control of
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transcription, the actual site of transcription initiation was identified (figure 5). Primer 
extension analysis was used to map the 5’ end of the UL75 (gH) mRNA. A primer 
complementary to the mRNA was designed that would bind downstream of the putative 
UL75 cap site. The primer was radiolabeled and then annealed with total cell RNA 
isolated from mock (lane 2) or late infected cells (lane 1). Moloney Murine Leukemia 
Virus reverse transcriptase was then used to generate a DNA product from the RNA 
template that corresponded to the 5’ end of the mRNA as described in the Materials and 
Methods. The size of the fragment was then determined by analysis on a 12.5% 
denaturing acrylamide gel and comparing the product to a radiolabeled molecular size 
marker.
There is one intense band that is apparent in the primer extension products that 
were obtained using whole cell RNA harvested at late times after HCMV infection of 
primary human fibroblasts (figure 5, lane 1). This band is 82 bases in length (*) as 
determined in comparison to the ladder that is also present on the autoradiograph in 
figure 5. There are several other bands present in the same lane that are significantly less 
intense. The smaller bands are likely the result of premature termination of the primer 
extension due to potential secondary structure within the GC rich 5’ end of the UL75 
mRNA. The longer bands are likely the products of nonspecific binding of the primer to 
the mRNA. Alternatively, the other bands could represent additional minor transcription 
start sites. The second most prominent band is 81 bases in length, immediately below the 
prominent 82 base product generated from gH. A longer exposure of the same gel 
demonstrated that the lower 81 base band is also present in the mock infected cell RNA 
(data not shown). This indicates that this band is generated from a nonspecific
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interaction of the probe with cellular RNA. The results from this assay therefore define 
the precise location of the 5’ end of the UL75 mRNA at 26 base pairs downstream of the 
TATA element.
2 Fragment sizes
FIG 5. Determination of the transcription initiation site of the HCMV UL75 gene. 
Primer extension analysis of the UL75 mRNA was performed on HCMV late mRNA (1) 
or RNA from mock infected human fibroblasts (2). The sizes of the products were 
determined by comparing to radiolabeled molecular weight marker, loaded at 2 different 
concentrations (Mw). The sizes of the ladder fragments are indicated to the right of the 
autoradiograph (Fragm ent sizes). The prominent product from the late RNA is indicated 
(*) as well as a faint band generated from the mock RNA indicated by an arrow.
Sequence analysis of the gH promoter
Once the 5’ end of the gH mRNA was determined, a knowledge of the consensus 
sequences that could influence transcription is essential in order to completely map the 
gH promoter. Analysis of the gH promoter sequence was performed using DNAsis and 
the results are presented in figure 6. There are several potential transcription factor
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binding sites. The sites that could be involved in regulation of the gH promoter will be 
focused on here.
A PEA3 site was identified at +23 to +28 relative to the UL75 mRNA cap site 
identified in this study. This transcription factor is a member of the ets family of proto­
oncogenes. Different members of the ets transcription factor family can bind to the same 
core sequence with similar affinities. The specific ets protein that binds to a particular 
sequence can depend on the sequence surrounding the core sequence and other proteins 
binding to adjacent regions (Janknecht and Nordheim, 1993). The presence of an ets 
transcription factor binding site within the gH promoter could be significant because ets 
proteins have been shown to be involved in the regulation of other HCMV promoters 
(Chen and Stinski, 2000). In addition, a putative W-element was identified immediately 
adjacent to the PEA3 element. The proteins that bind to the W-element are called W-Bl 
and W-B2. The W-element has been found to be important in the regulation of MHC 
class II gene expression (Cogswell, Austin, and Ting, 1991; Cogswell, Zeleznik-Le, and 
Ting, 1991). This could be significant because HCMV infects and can remain latent in 
monocytes (reviewed in Britt 1996), which express MHC class El. Thus, the cellular 
transcription factors that activate transcription through the W-element will likely be 
present in monocytes and may be important in regulation of the gH promoter in this cell 
type.
The PEA3 and W-elements are both present in an inverse orientation relative to 
the direction of transcription of the gH promoter. However, both factors have been 
reported as enhancers and therefore have the potential to be active in both orientations 
(Cogswell, 1991; Janknecht, 1993).
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- 4 5 3  CTGCAGGCTG TGGGTGGCGT GCCACCGCAC GGACTGATCG TCGGCGTCTG AGTACGTAGT 
GACGTCCGAC ACCCACCGCA CGGTGGCGTG CCTGACTAGC AGCCGCAGAC TCATGCATCA
- 3 9 3  TTTGAAC TC A ATCACGTAGC AAT AC AC GAT GCCGCGCGAC CCAGAGTCCG GCGGTAAAAA 
AAACTTGAGT TAGTGCATCG TTATGTG CTA CGGCGCGCTG GGTCTCAGGC CGCCATTTTT
T C F 1
- 3 3 3  CACCAACACG CAGTCGGGAA TCCGCCGACT TAATCGTACT TCGATGAAAA GACGGCGACG 
GTGGTTGTGC GTCAGCCCTT AGGCGGCTGA ATTAGCATGA A G CTA CTTTT CTGCCGCTGC
T C F 1 TCF1
- 2 7 3  GTACTTTTGC AACTCGGGTG GGAAAAGGCC TCCCAACAGG CGGTTGAGCG CCACAAATGA 
CATGAAAACG TTGAGCCCAC CCTTTTCCGG AGGGTTGTCC GCCAACTCGC GGTGTTTACT 
TC Fi AP 2 GMCSF
- 2 1 3  GGGAAAGACC CGCAGCAGGC GACGGTAGAT GTCCAGGTGC  3TGCGCTTAC CGATCCGCTT 
CCCTTTCTG G  GCGTCGTCCG CTGCCATCTA CAG G TCCACG AACGCGAATG GCTAGGCGAA
C /EB P  y lR E  W -elem ent
- 1 5 3  AC GC AC GTGA GGCAATCTCC GC AGAGC G TT CCCCTTCGAA TCAGCGTCGT CCCCACACCC 
TGCGTGCACT CCGTTAGAGG CGTCTCGCAA GGGGAAGCTT AGTCGCAGCA GGGGTGTGGG
vIRE C C A A T  box
- 9 3  GGACGGCATG ACTTACTCGC GTGTCCCCTC TTCTCCCTTC GCAGCGGCCA ATGACATCGT
CCTGCCGTAC TGAATGAGCG CACAGGGGAG AAGAGGGAAG CGTCGCCGGT TACTGTAGCA 
UL76 start codon aINF
+1 [—►
t a t a  I d a s  g c f
- 3 3  ATTAAATAGA CGGAGACGCG A CTTTTGTAA CCCGTAGCGC  CGCACCCGGG TGCTCCTTCC 
TA A TTTA TCT GCCTCTGCGC TGAAAACATT GGGCATCGCG GC<7TGGGCCC ACGAGGAAGG
T A T A  T C F I  G C F  W -e lem en t P EA 3
+ 2 8  TGGGATCC 
ACCCTAGG
FIG 6. The UL75 (gH) promoter sequence. The complete sequence of the 488 bp 
sequence containing the gH promoter upstream of the gH ORF. Consensus transcription 
factor binding elements have been indicated in bold on both strands. In the cases where 
sequences overlap, one of the sequences is underlined and the other italicized. The 
position of the label indicates the strand that contains the consensus site. The location of 
the UL75 transcription start site (+1) determined in this study and the UL76 start codon 
have also been indicated.
The GC-Factor (GCF) binding sites present at +3 to +9 in the promoter could also 
be important for regulation. Published reports indicate that this element acts as a 
repressor (Kitadai et al., 1993) and could potentially serve this purpose in the gH 
promoter. Similar sequences have also been identified in the HCMV pp28 (UL99) late 
gene promoter (Kerry, unpublished observations). Therefore, repression through the 
GCF element may be important in restricting HCMV late gene expression until after viral 
DNA replication.
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The TATA box that is present in the gH promoter does not exactly match the 
consensus (TAT A A), but it does share sequence identity with the HCMV UL99 and 
UL94 TATA elements. The presence of a TATA box was also shown to be required for 
activation by these two HCMV late gene promoters (Depto and Stenberg, 1992; Wing, 
Johnson, and Huang, 1998). There are several TCFI elements present in the gH 
promoter but the nonspecific nature of their consensus sequence (MAMAG) and the fact 
that a majority are present in the reverse orientation relative to the direction of 
transcription indicates that these elements are likely not significant for the control of 
transcription in the gH promoter. The CAAT box present in the gH promoter matches a 
consensus CAAT box sequence (Lim et al., 1993). The HCMV major immediate early 
protein IE72 has been shown to activate cellular promoters via direct interaction with the 
CCAAT box binding factor CTF1 (Hayhurst et al., 1995). Alternatively, a CAAT box 
found in the HCMV DNA polymerase promoter was found to have a slight repressive 
effect (Kerry, Priddy, and Stenberg, 1994). An additional upstream CCAAT enhancer 
binding protein (C/EBP) element in the gH promoter could also be involved in the 
regulation of gH transcription (Landschulz et al., 1988).
The gH promoter also contains elements that could be responsive to both 
interferon alpha (IFNa) and gamma interferon (ylRE). Interestingly, oligonucleotide 
array analysis of cellular gene expression subsequent to infection with HCMV has 
demonstrated that several cellular genes responsive to interferons are activated in 
response to viral infection (Zhu et al., 1998). Thus, these cellular proteins could be 
involved in regulating HCMV gene expression. In herpes simplex virus infection, alpha 
and gamma interferon primarily have a negative regulatory effect on gene expression (De
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Stasio and Taylor, 1989; Nicholl and Preston, 1996). In addition, the gamma-interferon 
response element has a negative regulatory function in the HCMV UL98 promoter 
(Jervey, personal communication) and could have the same effect in the gH promoter.
In addition to sites identified using the DNAsis database, a putative DAS element 
was identified that is immediately downstream of the UL75 mRNA cap site. As 
discussed in the Introduction, this element has been demonstrated to be important in the 
regulation of several herpes simplex vims true late gene promoters (Guzowski, Singh, 
and Wagner, 1994). The presence of the consensus sequence in the HCMV gH promoter 
could be significant and will be analyzed in this study.
Deletion analysis of the gH promoter
In order to determine how the expression of gH is controlled, the promoter must 
be mapped. One basic method used to map promoters is to remove portions of the 
promoter and analyze the effect that these deletions have on promoter function.
Sequences upstream of the gH open reading frame (ORF) were cloned into a CAT 
reporter vector to generate gHCAT, as described in Materials and Methods. Preliminary 
experiments were performed to determine that the -453 to +35 sequence that was 
originally cloned had activity in response to viral infection. Once this was determined, 
deletions of promoter sequences were generated to begin to map the sequences that are 
important for promoter activity. A schematic representation of all the deletion constructs 
that were generated is presented in figure 7. In the first series of experiments, various 
restriction enzyme sites were used to generate deletions within the upstream portion of 
gHCAT promoter containing sequences to +35. In addition, PCR mutagenesis was used 
to generate deletions to —81 and —38 relative to the transcription initiation site. The
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original purpose of the deletion of promoter sequences to -81 (gHCAT81) was to remove 
sequences of the adjacent UL76 ORF. The construct containing deletion of gH promoter 
sequences to -38 (gHCAT38) was generated to remove almost all sequences upstream of 
the TATA box in the gH promoter. The deletion to TATA was generated because 
previous studies of HCMV late gene promoters indicated that sequences upstream of the 
TATA box are not required for control of expression (Depto and Stenberg, 1992; Kohler













































FIG 7. Schematic representation of all of the gHCAT deletion constructs. The 
full length gH promoter fragment is indicated at the top of the figure. This 
fragment was cloned into a CAT vector to generate gHCAT. On the line 
representing the full length promoter Stu I, BstB I and Sma I sites are indicated. 
These sites were used to generate the deletions indicated below. Deletions to -81 
and -38 were generated using PCR mutagenesis.
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Preliminary data had already indicated that the gH promoter is not activated in the 
absence of viral infection. Therefore, the deletion constructs diagramed in figure 7 were 
transfected into primary human fibroblasts and evaluated for their response to viral 
infection. The data presented in figure 8 indicate that there is no significant difference in 
promoter activity upon deletion of gHCAT promoter sequences to -38. Paired student t- 
tests between each of the constructs all yielded p-values greater than 0.05 indicating no 
significant differences. The results of these experiments indicate that the gH promoter, 
like the UL94 (Wing, Johnson, and Huang, 1998) and the pp28 (Kohler et al., 1994) 
promoters, does not require sequence elements upstream of the TATA element to activate 
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FIG 8. Analysis of gH deletion mutants. The full length or the indicated deletion 
mutants were transfected into HFFs and superinfected with HCMV. At 72 hours post­
infection the cells were harvested and assessed for CAT activity. Data is represented 
relative to full length gHCAT and is an average +/- standard deviation of at least 2 
experiments performed in duplicate.
gHCAT gHCAT245 gHCAT117 gHCAT81 gHCAT38
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Previous studies of HCMV late gene promoters indicated that sequences upstream 
of the TATA box are not required for control of expression (Depto and Stenberg, 1992; 
Kohler et al., 1994; Wing, Johnson, and Huang, 1998). Analysis of the HCMV UL94 
promoter also indicates that downstream promoter elements work in combination with 
upstream elements to regulate transcription (Wing, Johnson, and Huang, 1998). The 
potential cooperation of downstream promoter elements with upstream elements in 
HCMV late gene promoters prompted the construction of promoter constructs with the 
+14 to +35 sequences deleted in addition to upstream sequences. These constructs were 
generated using the Sma I site that cuts at +14, indicated in figure 7. The resultant 
constructs were transfected into fibroblasts and evaluated in response to viral infection. 
These data are presented in figure 8.
Upon deletion of sequences from +14 to +35 in the context of the full length 
promoter, a slight increase in promoter activity was observed. The difference in activity 
between gHCAT and gHCATA14, though not significant (p>0.05), could indicate the 
presence of a weak repressor present between +14 and +35. Data presented in figure 9 
also indicates the presence of possible control elements that exist in the sequences 
upstream of the TATA element in the gH promoter that function in the absence of 
sequences from +14 to +35. The deletion of sequences to -245 in the A14 construct 
produces a significant increase (p=0.009) in activity when compared to the full length 
construct. It is possible that removal of sequences between —453 and —245 could result in 
a nonspecific increase in transcription initiation. A similar effect has been observed 
previously with the HCMV DNA polymerase and pp28 HCMV promoters (Kerry, 
unpublished observations). In order to determine if the deletion of sequences from -453
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to -245 in the gH promoter results in a specific or nonspecific increase in activity, further 
analysis of this region would be required.
gHCAT gHCAT gHCAT245 gHCAT117 gHCAT81 gHCAT38 
A14 A14 A14 A14 A14
FIG 9. Analysis of gH deletion mutants in the absence of the +14 to +35 sequence. 
The full length or the indicated deletion mutants were transfected into HFFs and 
superinfected with HCMV. At 72 hours post-infection the cells were harvested and 
assessed for CAT activity. Data is represented relative to full length gHCAT and is an 
average +/- standard deviation of 3 experiments performed in duplicate. The constructs 
marked with an asterix (*) have significantly different activity than the previous 
deletion mutant (p<0.05).
The activity of the gHCAT245A14 construct is approximately double that of the 
full length gHCAT construct. However, when sequences between -245 and -117 are 
deleted, there is a significant reduction in activity (p=0.05), returning back to wild type 
levels. These data suggest that there are one or more sequence elements between -245 
and -117 that activate transcription. This effect is only observed in the absence of the
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+14 to +35 sequence, suggestive of a downstream activation domain that is dominant, 
similar to the UL94 promoter (Wing, Johnson, and Huang, 1998). Further deletion of the 
-117 to -81 sequence in the context of the A14 construct resulted in a significant 
(p=0.007) 2.5 fold increase in activity. This implies that there is a repressor element 
between -117 and -81. Examination of these sequences revealed the presence of a 
putative ylRE site that could be responsible for this repression. In fact, studies of the 
HCMV UL98 promoter show that this element can be involved in the repression of an 
HCMV early promoter (Jervey, personal communication). Deletion of sequence from -  
81 to -38 in the absence of the +14 to +35 sequence returns the activity to wild type 
levels. This suggests another activation domain between —81 and —38. A consensus 
CAAT box is present in these sequences that could act as an activator in the absence of 
the dominant downstream control element.
Deletion analysis of the HCMV gH promoter has identified sequences that will be 
focused on in this study. The primary finding of these experiments is that sequences 
upstream of the TATA box are not necessary to activate expression to wild type levels in 
transient assays. However, there do appear to be sequences upstream of the TATA box 
that are responsible for some level of regulation of expression. The effect of these 
upstream control sequences is only evident in the absence of downstream control 
elements. The consensus sequences present in the potential downstream control element 
are a PEA3 element and a W-element. Data presented in figure 9 also indicate that 
sequences between -38 and +14 can activate transcription to near wild type levels. In 
order to further analyze promoter sequences that are important for transcriptional control, 
mutations were generated in sequences between -38 and +35.
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Mutational analysis of the gH promoter
One of the first regions within the gH promoter that was focused on in these 
experiments is the +14 to +35 gH promoter region. The reason for focusing on this 
region was the interesting effects that were observed with the promoter deletion mutants 
when this region is removed (figure 9). The results suggest that there may be a dominant 
downstream control element in the gH promoter similar to the one present in the HCMV 
UL94 promoter (Wing, Johnson, and Huang, 1998). In order to study this region, the two 
consensus enhancer elements present in this sequence were mutated. These elements are 
the W-element and the PEA3 element. The specific sequence mutations that were 
generated are shown in figure 10. These consensus elements were targeted to determine 
if they were responsible for the transcriptional control exhibited by the +14 to +35 
sequences (figure 9). The indicated mutations were generated in the context of the full 
length promoter. The promoter constructs containing the mutant W-element 
(gHCATWX) and mutant PEA3 element (gHCATPX) were transfected into fibroblasts 
and evaluated for their response to viral infection. The data obtained in these 
transfection-superinfection experiments are shown in figure 11.
As demonstrated by the data presented in figure 11 the only construct that has 
significantly different activity (p=0.008) than wild type is gHCATPX, a construct that 
contains sequence mutation in the PEA3 element (figure 10) in the full length promoter. 
The activity of the promoter mutant gHCATPX is only 15% of wild type gHCAT. These 
data are intriguing because the gHCATA14 construct has the PEA3 element deleted, but 
does not have reduced activity. Mutation of the W-element had no effect on gH 
promoter activity indicating that it is not important for control of the gH promoter in this
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cell type. The PEA3 mutation was also generated in the context of the gH minimal 
promoter and tested in transfection. The data are presented in figure 11 indicate that 
there is also a significant loss of activity when the PEA3 element is mutated in the 
context of gHCAT38PX. The significance of these data will be elaborated further in the 
Discussion.





TATA DAS GCFTCF1 w - PEA3
element
+35
+ +14 +35 +
GGGTGCTCCTTCCTGGGATCC
W X  m u tation  GTCTAGACCTTCCTGGGATCC  
P X  m u tation  GGGTGCTC TCTAGAGGG ATC C
FIG 10. Schematic representation of the WX and PX mutations. The top line is a 
linear representation of the gH promoter originally cloned. The coordinates of each 
deletion mutant are indicated. The second line is an expanded representation of the 
-38 to +35 gH promoter fragment with consensus transcription factor binding sites 
indicated. The top line of text is the wild type sequence between +14 and +35. 
Mutations were generated in the W-element and PEA3 element as indicated in the 
sequence below. The W-element is indicated by bold underlined text and the PEA3 
element is in bold text. The italicized text indicates the mutations that were 
generated in each consensus site.
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gHCAT gHCATA14 gHCATWX gHCATPX gHCAT38 gHCAT38PX
FIG 11. Analysis of the gH WX and PX mutant activity. The W-element (WX) and 
PE A3 (PX) consensus transcription factor binding sites between +14 and +35 were 
mutated to Xba I sites. The full length or the indicated mutants were transfected into 
HFFs and superinfected with HCMV. At 72 hours post-infection the cells were 
harvested and assessed for CAT activity. These data represent the average raw data +/- 
standard deviation from at least 2 experiments with each sample performed in duplicate.
There is another potentially important transcriptional control element present in 
this region of the gH promoter. This element is called the downstream activation 
sequence (DAS) and has been identified and found to be important for activation of 
several herpes simplex virus late gene promoters including the HSV UL38 promoter 
(Guzowski, Singh, and Wagner, 1994) as discussed in the Introduction. The DAS 
element at +1 to +6 (figure 6) in the HCMV gH promoter was targeted for mutation as 
indicated in figure 12.
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TATA TCF1 DAS GCF W- PEA3 
element
J+35
+ 7  + 1 5 l
VGT AAC C C GTAGCGCCGCAC  C C Gv  
DAS mutation GTAACCCGTAATAACGCACCCG
FIG 12. Schematic representation of the DAS element mutation. The first line is a 
linear representation of the gH promoter originally cloned. The coordinates, relative 
to the UL75 cap site of each deletion mutant are indicated. The second line is an 
expanded representation of the -38 to +35 gH promoter fragment with consensus 
transcription factor binding sites indicated. The top line of text is the wild type 
sequence between -7 and +15. The GCF and DAS elements are indicated in the wt 
sequence. The DAS element is bold and italicized and the GCF element is bold and 
underlined. The mutated bases in the DAS mutation line are indicated in bold.
The DAS element was mutated in the context of the full length gH promoter 
(gHCATDAS) and in the context of the minimal promoter construct (gHCAT38DAS). 
These constructs were transfected into primary human fibroblasts and assessed for their 
response to HCMV infection. As demonstrated by the data in figure 13, mutation of the 
DAS element does not have a significant effect on activation by the gH promoter, either 
in the context of the full length or minimal promoter constructs. This does not eliminate 
the DAS element from potentially being important for activation in other cell types, but
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in the context of these assays in primary human fibroblasts, the DAS element is not 
necessary for activated transcription from the gH promoter.
Our studies thus far demonstrated that only mutation of the PEA3 element within 
the full length promoter and in the context of the promoter deleted to -38 (figure 11) had 
a significant effect on gH promoter activity. In addition, sequences upstream of the 
TATA element can be deleted with no significant effect on transcriptional control (figure 
8). Thus, sequences between -38 and +14 are sufficient to activate transcription to near 
wild type levels (figure 9).
5 0 - 
45 •
4 0 - j
3 5 - T
gHCAT gHCATDAS gHCAT38 gHCAT38DAS
FIG 13. Analysis of the gH DAS mutant activity. The consensus DAS element 
present immediately downstream of the UL75 cap site was mutated in the context of 
gHCAT (gHCATDAS) and gHCAT38 (gHCAT38DAS). The full length or the 
indicated mutants were transfected into HFFs and superinfected with HCMV. At 72 
hours post-infection the cells were harvested and assessed for CAT activity. These 
data represent the average raw data +/- standard deviation from 2 experiments with 
each sample performed in duplicate.
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To determine if any other elements within this region contribute to gH promoter 
activity, scanning mutants between —25 and +9 were generated as shown in figure 14.
All of the mutations in figure 14 were generated in the context of the minimal promoter 
construct in the presence or absence of the PX mutation.
-38 +35
ATC GTATTAAATAG ACGGAG AC GCGACTTTTGTAAC CC GIAGCGCCGCACC CGGGTGCTC CTTCCTGGGATC C
TATA TCF1 DAS GCF W-element PEA3
-36 CGTATTAAATACTAGTAGACGCGAC -12  m 3 0  m u ta tio n
-25 GACGGTCTAGAGACTTTTGTAACCCG +1 m 25  m u ta tio n
-21 GAGACGCGATCGATGTAACCCGTAGC +5 m l7  m u ta tio n
-19 GACGCGACTTTTGGTATACGTAGCG +6 m l2  m u ta tio n
-7  GTAACCCGTAGATATCCACCCGGG +17 m 2  m u ta tio n
FIG 14. Mutations generated between -25 and +10. The top line of sequence is the wild 
type promoter sequence from —38 to +35 with all consensus elements indicated in bold. 
The DAS element is also italicized and the GCF element, which it overlaps, is 
underlined. Each line of sequence below indicates one of the primers used, along with 
each of their complements, in PCR mutagenesis to generate each mutation. The 
underlined bases in each primer are the exact bases that were mutated. The mutations 
were generated in the context of gHCAT38 and gHCAT38PX.
The data in figure 15 demonstrate that each of the single mutant constructs had 
slightly reduced activity, although none was significantly reduced compared to 
gHCAT38. This indicates that no individual sequence element within the minimal 
promoter, with the exception of the PEA3 site, has a significant effect on promoter 
activation. Each mutant in the context of the PEA3 mutation reduced activity to almost 
identical levels as gHCAT38PX. Therefore, there is no indication from the data 
presented in figure 15 that that the PEA3 element is working in combination with any of 
the sequences between -25 and +9.
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FIG 15. Analysis of gHCAT38 mutant constructs. A series of mutations was generated 
between -25 and +10 in the context of the gHCAT38 construct individually or in 
combination with the PX mutation. The full length or the indicated mutants were 
transfected into HFFs and superinfected with HCMV. At 72 hours post-infection the 
cells were harvested and assessed for CAT activity. The data presented represents 
average +/- standard deviation of the raw data corrected for protein levels from 3 
separate experiments with each sample in duplicate.
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Overall, the mutational analysis does give important information about the 
function of the gH promoter. First, sequences around the PEA3 element are important for 
transcriptional control by the gH promoter. Deletion of the PEA3 element does not 
reduce promoter activity, while mutation of the PEA3 element in the context of gHCAT 
and gHCAT38 does reduce promoter activity by three to five fold. This could indicate 
that a repressor is binding to sequences adjacent to or overlapping the PEA3 element. 
Mutation of the DAS element did not have a significant effect on promoter activity in the 
context of the experiments performed, indicating that the DAS is not involved in 
promoter activation in fibroblasts. The DAS mutation as well as the m2 mutation in 
gHCAT38m2 both mutated the GCF element and did not have a significant effect on 
promoter activity. The only other consensus element that was mutated, TCF1 in 
gHCAT38ml7, also did not have a significant effect on promoter activity. All of the 
other mutants caused limited but not significant reductions in promoter activity. To 
further analyze transcriptional regulation by the gH promoter, we next examined protein 
binding to the gH promoter sequence.
Analysis of protein binding to the gH promoter sequences
DNA sequence within a promoter can directly effect transcription by generation 
of secondary structure, but primarily promoter sequence affects transcription by 
interaction with proteins. For this study, protein binding to gH promoter sequences were 
analyzed by gel mobility shift assays. Fragments within the gH promoter were used as 
both probes and competitors. In the first series of experiments, sequences from -117 to 
+35 were examined for protein binding. The sequences contained in this promoter 
fragment can activate transcription to wild type levels (figure 8). Deletion of portions of
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this fragment, -117 to -81 and -81 to -38 in the absence of +14 to +35 sequences had 
significant effects on transcriptional activation by the promoter (figure 9). These data 
suggested that analysis of protein binding to the -117 to +35 may reveal some of the 
mechanisms of activation by the gH promoter. Later studies use subfragments of this 
probe as both probe and competitors. The fragment from -117 to +35 gH and the 
subfragments used as competitors and probes can be seen in figure 16.
Gel shift analysis using the -117 to +35 probe is presented in figure 17. The 
binding assay was performed using nuclear extracts isolated from primary human 
fibroblasts. The mock infected cell nuclear extracts were harvested at 72 hours after the 
cells were plated. The 72 hour infected cell nuclear extracts were generated from 
Fibroblasts infected with the Towne strain of HCMV and harvested at late times (72 
hours) after infection.
Bands a and b (figure 17) are a doublet prominent in infected cell extracts. These 
proteins are specific for binding to the gH promoter because they are competed by 100 
fold excess unlabeled probe (lane 7) but not by the 147 bp nonspecific competitor (lane
8). Band a can be seen as a very faint band in mock extracts (lanes 2 and 4) but binding 
increases significantly in the infected cell nuclear extracts. This could indicate that band 
a is a cellular protein that is expressed at much higher levels during infection.
Band b can only be seen in late infected cell nuclear extracts (lanes 6,8,9) indicating that 
this protein is likely a viral protein or potentially a cellular protein that is significantly up 
regulated in infected cells. Band c is present in the mock infected cell extracts (lanes 2,4, 
and 5) and is also specific because it is competed off by the specific competitor (lane 3), 
but is not present in the infected cell extracts. The protein binding to promoter sequences
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that generates band c could represent a cellular repressor that is either down regulated 










-117 S w C l -m a m tf 81
-95 ■ ■ a  a  : ■ ■ a ■ a m a m n • -65
-8 0  | - -38
FIG 16. Schematic representation of the -117 to +35 gel shift probe. The top line 
indicates the -117 to +35 gH promoter fragment with consensus transcription factor 
binding sites shown. The second line is a blow up of the -117 to -38 promoter sequence 
with the consensus transcription factor binding sites indicated. The next 3 lines are 
schematic representations of oligonucleotide subfragments that were generated to analyze 
protein binding to the -117 to -38 gH promoter sequences. The -117 to -81 fragment 
contains all but 1 base of the consensus yERE. The -95 to -65 fragment contains the 
whole consensus ylRE and the -80 to -38 fragment contains the consensus aINF element 
and CCAAT box.
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72 hr InfectedMockProbe
1 2 3 4 5  6 7 8 9
Competitor - - sc nc pol - sc nc pol
FIG 17. Analysis of protein binding to the gH promoter. Gel shift analysis using -117 
to +35 gH promoter fragment as a probe. Nuclear extracts from mock infected human 
fibroblasts (Mock) and infected human fibroblasts harvested at late times after infection 
(72 hour infected) with HCMV were used in binding assays, sc — 100 fold excess of 
unlabeled probe DNA, nc- 100 fold molar excess of a 147 bp nonspecific competitor, 
pol -  100 fold molar excess of 147 bp fragment from the HCMV DNA polymerase 
(UL54) promoter. Labels a, b, and c indicate prominent bands that are addressed in the 
text.
(i) Analysis of protein binding to the gH promoter sequences from -117 to -38 
To further analyze this binding we performed gel shift analysis using 
subfragments of the -117 to +35 sequence. Deletion analysis revealed that sequences 
from -117 to -81 are involved in repression, whereas sequences from -81 to -38 are 
involved in activation in the absence of the dominant downstream activation domain.
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Our preliminary analysis described above (figure 17) suggests the binding of both 
potential activators (bands a and b) and repressors (band c) of transcription. Based on 
these data we would predict that a protein involved in activation of the gH promoter 
would bind to sequences from -8 0  to -38. This binding would be restricted to or 
increased at late times after infection. We therefore examined binding to this region.
P  M o c k  72 h r  in fe c te d
Lane 1 2 3 4 5 6 7 8 9
Competitors sc 117 95 - sc 117 95
FIG 18. Analysis of protein binding to sequences between -80  and -38 in the gH 
promoter. Gel shift analysis was performed using the -80 to —38 fragment from the 
gH promoter as a probe. Nuclear extracts from mock infected human fibroblasts 
(Mock) and fibroblasts infected with the Towne strain of HCMV and harvested at 
late times (72 h r  infected) after infection were used. The competitors were used at 
100 fold molar excess and were unlabeled probe (sc), gH promoter fragment 
containing sequences from -117 to —81 (117), and a gH promoter fragment 
containing sequences from -95 to -65 (95).
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On the gel shift analysis using the -80 to -38 probe (figure 18), several bands 
were observed that indicate multiple proteins binding to this region. As previously 
discussed, this region is involved in activation, and it would be expected that a protein 
involved in activation at late times after infection would bind exclusively or in increased 
levels at late times. Band a’ is a prominent band that fits this profile. The protein 
binding to probe sequences to generate this band is a cellular protein present at low levels 
in uninfected cells (lane 2) but is greatly increased in late infected cell nuclear extracts 
(lane 6). Further analysis could be used to identify the specific protein to generate band 
a’ including mutation of the consensus CAAT box and cdFN element located within this 
region (figure 6). Two other prominent bands are indicated, bands b’ and c \
Intriguingly, bands b’ and c \  like band a’, are competed with DNA fragments containing 
other regions of the -117 to -38 region (lanes 4, 5, 8, 9). This suggests that there may be 
a common protein binding to several sites within this region. To further assess this 
possibility, we examined direct binding to the -95 to -65 sequences.
The probe from —95 to -65 contains a consensus ylRE (figure 6). There are two 
specific bands formed with this probe, a” and b”, that are present in both uninfected cells 
(Mock) and at late times after infection (72 hr infected). Neither band was efficiently 
competed with sequences from -117 to -81 o r-80  to -38 (figure 19, lanes 8 and 9). This 
suggests that the proteins binding to the -95 to -65  probe to generate bands a” and b” are 
likely binding to the consensus ylRE site. This is also supported by the fact that protein 
binding is up regulated in HCMV infected cell extracts. It is known that the y  interferon 
response pathway is activated in response to HCMV infection (Zhu et al., 1998).
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FIG 19. Analysis of protein binding to sequences between —95 and -65 in the gH 
promoter. Gel shift analysis was performed using the -95 to -65  fragment from the 
gH promoter as a probe. Nuclear extracts from mock infected human fibroblasts and 
fibroblasts infected with the Towne strain of HCMV and harvested at late times (72 
hr) after infection were used. The competitors were used at 100 fold molar excess 
and were unlabeled probe (sc), a gH promoter fragment containing sequences from — 
117 to -81 (117), and a gH promoter fragment containing sequences from -80 to -38 
(80). P is the probe alone. Bands a” and b” are discussed in the text.
To complete the analysis of proteins binding to the -117 to -38 gH promoter 
fragment, direct binding analysis was carried out using the -117 to -81 promoter fragment 
as a probe. Transfection analysis indicates that there is a potential repressor protein 
binding to this sequence (figure 8). The results of this analysis are presented in figure 20.
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Bands a* and b* (figure 20) represent proteins that are interacting with the —117 
to —81 gH promoter fragment. As we observed with gel shifts utilizing other 
subfragments (figures 18 and 19) the data in figure 20 also suggests a common factor 
binding to these regions or possible cooperative binding.
P Mock 72 hr infected
Lane 1 2 3 4 5 6  7 8  9
Competitors - - sc 95 80 - sc 95 80
FIG 20. Analysis of protein binding to sequences between —117 and —81 in the gH 
promoter. Gel shift analysis was performed using the -117 to -81 fragment from the 
gH promoter as a probe. Nuclear extracts from mock infected human fibroblasts 
(Mock) and fibroblasts infected with the Towne strain of HCMV and harvested at late 
times (72 hr Infected) after infection were used. The competitors were used at 100 fold 
molar excess and were unlabeled probe (sc), a gH promoter fragment containing 
sequences from -95 to -65 (95), and a gH promoter fragment containing sequences 
from -80  to -38 (80). P  represents the probe. Bands a* and b* will be discussed in the 
text.
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Together, these data show a complex pattern of binding with various regions 
possibly binding common proteins or protein-protein interactions amongst the factors. 
This is in accordance with the complexity of promoter activation observed in the absence 
of the dominant downstream activation domain. Future experiments including 
mutagenesis of promoter sequences and gel supershift analysis could be performed to 
specifically identify proteins binding to these sequences. Any mutations from this region 
found to have an effect on promoter activity could then be tested in the context of the 
virus as previously described (Kohler et al., 1994). These experiments will likely form 
the basis for future studies.
(ii) Analysis of protein binding to the gH promoter sequences from -38 to +35
Transfection data demonstrated a critical role for sequences from -38 to +35 in 
gH promoter activation. To address proteins binding to this region, a -38 to +35 gH 
promoter fragment was used as a probe in gel shift analysis. The probe and DNA 
subfragments generated to be used as competitors are presented in figure 21. The 
competitors were designed to focus on the region downstream of the 5’ mRNA cap site as 
it was shown in mutational analysis that specific sequences within this region were 
involved in activation of the gH promoter.
The results of this gel shift analysis are presented in figure 22. The data in this 
figure shows multiple proteins binding (bands A, B, C) to the -38 to +35 promoter 
fragment (lane 2). The GWP competitor that contains sequences from +1 to +35 
efficiently competes bands A and B at 100 fold molar excess with increased competition 
observed at 300 fold molar excess (lanes 4 and 5). This suggests that the proteins binding 
to the -38 to +35 sequences are primarily binding to sequences between +1 and +35.
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PEA3 WT +GGTGCTCCTTCCTGGGAT<!& &
PEA3PX
+35
;t g c t c t c t a g a g g g a t c c
DAS GTAACCCGTAGCGCCGCAC1
-7 +15
DAS mut GTAAC C C GTAATAAC GCAC CCG
FIG 21. Fragments generated for gel shift competition analysis. The -38 to +35 
fragment was used as a probe in gel shifts and is shown as the top line of sequence. 
Consensus transcription factor binding sites are indicated in bold. The DAS element is 
also italicized and GCF element is underlined to differentiate these overlapping 
elements. The coordinates relative to the UL75 cap site are indicated. The sequences of 
the oligonucleotide competitors are indicated below the probe sequence. The different 
competitors contained all sequences downstream of the cap site (GWP), sequences from 
+16 to +35 that target the PEA3 element (PEA3 WT), this same fragment with the 
PEA3 element mutated with the mutations indicated in bold (PEA3 PX), a fragment 
containing sequences from -7  to +15 targeting the DAS element (DAS), and this same 
fragment with the DAS element mutated with the mutations indicated in bold (DAS 
mut).
When the competitor containing sequences from +16 to +35 that includes the 
PEA3 site, was used, competition was inefficient at 100 fold molar excess, but some 
competition was observed at 300 fold molar excess. This suggests that proteins are 
binding to sequences outside of the PEA3 element between +1 and +35. This affect 
could also be caused by inefficient binding to the shorter +16 to +35 promoter fragment.
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P 72 sc IR1
I  I >
m i s #B
#- C
Lane 1 10 11 12 13 14
FIG 22. Analysis of protein binding to the -38 to +35 gH promoter. Gel shift 
analysis using —38 to +35 gH promoter fragment as a probe. Nuclear extracts from 
infected human fibroblasts harvested at late times after infection (72 hrs.) with 
HCMV were used in binding assays. The competitors were used in 100 fold and 300 
fold molar excess, sc — 100 fold excess of unlabeled probe DNA, GW P — a +1 to 
+35 gH promoter fragment, PEA3 WT - a+16 to +35 gH promoter fragment, PEA3 
PX - a+16 to +35 gH promoter fragment containing mutations in the PEA3 
consensus transcription factor binding site, DAS -  a -7  to +15 gH promoter 
fragment, DAS m ut -  a -7  to +15 gH promoter fragment with mutations in the 
consensus DAS element. IR1 - nonspecific comDetitor
Competition with a fragment targeting the DAS and GCF elements containing 
sequences from -7  to +15 (DAS) was also performed (lanes 10 and 11). The prominent 
doublet containing bands A and B was competed using 100 fold molar excess DAS 
competitor (lane 10). Interestingly, when a mutation was generated in the DAS element 
(DAS mut, figure 21), the fragment was no longer able to compete bands A and B (lanes
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12 and 13 vs. lanes 10 and 11). This strongly suggests that proteins are binding to the 
DAS element. This same mutation was tested in transfection and did not have any effect 
on activation by the gH promoter (figure 12). In contrast, the DAS mutation used was 
found to have a significant effect on activation and protein binding to the HSV UL38 
promoter (Guzowski and Wagner, 1993). This fact suggests that the HSV UL38 
promoter and the HCMV gH promoter have alternate functional uses for the DAS 
element.
The GWP competitor also competed band C (lanes 4 and 5) while the PE A3 WT 
and PX competitors lost the ability to compete band C (lanes 6-9). This indicates that the 
protein binding to the gH promoter and generating band C is likely binding to sequences 
between +1 and +15. Band C was also not competed by the DAS competitors (lanes 10- 
13). Together this suggests that the protein generating band C is likely binding around 
+15 to sequences that overlap the PE A3 and DAS competitors.
Competition analysis of binding to the -38 to +35 region indicated that most of 
the proteins binding to the gH promoter in this region, interacted with the +1 to +15 
sequences directly or through protein-protein interaction (figure 22). Direct binding of 
proteins to +1 to +35 gH promoter sequences was performed to further analyze protein 
binding to the important gH promoter sequences downstream of the 5 ’ mRNA cap site 
(figure 23). In this experiment, both uninfected and late infected cell nuclear extracts 
were used. The purpose for performing these experiments is to determine if specific 
proteins bind to promoter sequences to repress transcription in mock infected cell nuclear 
extracts or activate transcription in late infected cell nuclear extracts. The arrow indicates 
a specific band that is observed only in late extracts. This band could represent a late
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viral or cellular protein up regulated at late times that binds to gH promoter sequences to 
activate transcription.
Extract - Mock 72a 72b
Competitor sc sc - sc
FIG 23. Analysis of binding to the +1 to +35 gH promoter fragment. Gel shift analysis 
using the +1 to +35 gH promoter fragment as a probe. Nuclear extracts from infected 
human fibroblasts harvested at late times after infection (72a and 72b.) with HCMV were 
used in binding assays, sc -  specific competitor, 100 fold molar excess of unlabeled 
probe.
The pattern of binding seen with the -38 to +35 probe (figure 22) indicates that 
there are at least two to three specific proteins or protein complexes binding to the gH 
promoter minimal activation sequences (figure 8). Competition analysis presented in 
figure 22 shows that protein complexes generating bands A and B are likely formed with 
sequences between + 1 and +15, whereas band C binds to sequences overlapping this
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region. This was somewhat surprising because earlier transfection analysis had 
implicated the PEA3 element as being important for transcriptional control of the gH 
promoter. We therefore examined direct binding to the PEA3 element.
The analysis of protein binding to the PEA3 element present in the gH promoter 
was achieved using the +16 to +35 promoter fragment as a probe. The PEA3 element is 
the only complete consensus element present in this fragment. The results from this 
analysis can be seen in figure 24. In this experiment, we used nuclear extracts from 
infected cells harvested at late times after infection (72hr infected) and from infected 
cells with viral replication restricted to early times with phosphonoacetic acid (PAA), a 
DNA synthesis inhibitor. The purpose for using these two different extracts was to 
determine if a specific protein or proteins could be detected binding at early or late times 
after infection. Analysis of the binding showed that there are 2 major proteins or protein 
complexes that specifically bind to this sequence (bands land 2). There was no apparent 
difference observed between early and late infected extracts suggesting that there are no 
specific proteins binding to this portion of the promoter that are involved in the regulation 
of the kinetics of gH promoter activation.
There are two specific bands present, bands 1 and 2, that could be competed with 
the unlabeled probe (lanes 3 and 9). However, mutation of the PEA3 element (PX) 
reduced the ability of this fragment to compete. Therefore these complexes are likely 
formed at the PEA3 element. Interestingly, specific competition of band 1 was observed 
with a fragment from -7  to +15 that contains the DAS element. This suggests an 
interaction between proteins that are binding to the DAS and PEA3 elements. When the 
DAS element is mutated in the context of the DAS fragment (DAS mut), the ability to
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compete band 1 is reduced, but competition of band 2 is observed. This complex pattern
of competition, like previous experiments, indicates the presence of several proteins
binding to this portion of the promoter that could affect transcription.
7 2  h r  In fe c te d ________   7 2  h r  +  P A A
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13
Competitor - - sc PX D Dm I - sc PX D Dm I
FIG 24. Competition analysis of binding to the +16 to +35 gH promoter fragment. Gel 
shift analysis using the +15 to +35 gH promoter fragment as a probe. Nuclear extracts 
from infected human fibroblasts harvested at late times after infection (72 h r Infected)
with HCMV or extracts extracts restricted to early times (72 h r  + PAA)were used in
binding assays. The competitors were used in 100 fold molar excess, sc -  100 fold 
excess of unlabeled probe DNA, PX - a+15 to +35 gH promoter fragment containing 
mutations in the PEA3 consensus transcription factor binding site, D -  a -5  to +17 gH 
promoter fragment, D m - a -7  to +15 gH promoter fragment with mutations in the 
consensus DAS element, I- nonspecific competitor, NS- a nonspecific band.
To further analyze PEA3 binding, direct binding to a probe containing wild type 
sequences from +16 to +35 (PEA3 WT, figure 21) and a probe containing the same
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sequence with the PE A3 element mutated (PE A3 PX, figure 21) was performed. This 
analysis is presented in figure 25.
. v .
Lane 1 2 3 4  5 6 7 8
Probe W T PX
Extract - M L E  - M L E
FIG 25. Direct protein binding to wild type and mutant +16 to +35 fragment from the 
gH promoter. Gel shift analysis was performed to determine protein binding to this 
sequence in infected cells at early and late times and in mock infected cells. The 
labeled probes used contained wild type sequences from +16 to +35 (WT) and a 
mutant probe containing sequences from +16 to +35 with mutations that change a 
PEA3 binding site to an Xba I site (PX). The extracts used were nuclear extracts from 
mock infected human fibroblasts (M), fibroblasts infected with the Towne strain of 
HCMV and harvested at 72 hours (L), and fibroblasts infected with the Towne strain of 
HCMV with phosphonoacetic acid, a chemical inhibitor of viral DNA replication, and 
harvested at 72 hours (E).
There are four specific bands that have been indicated on the gel shift analysis in 
figure 24. Complex 1 bound specifically to sequences that contained the wild type PEA3 
element. Therefore, it is likely that this band is generated by a cellular protein binding
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directly to the PEA3 element, although inconsistancies were seen in this band between 
gel shifts (figures 24 - 26). The differences that are seen in the protein binding patterns 
with the +16 to +35 probe (figures 24 and 25) can possibly be explained by the fact that 
the proteins were quantitated in the direct binding analysis to the WT and PX probes 
(figure 25) versus equivalent volumes of extract added to the binding reactions in the 
competition analysis (figure 24).
To attempt to identify the proteins that are interacting with the gH promoter 
sequences supershift analysis was performed. In gel supershift analysis, an antibody 
binds to a protein that is in tum binding to the probe fragment, the band generated by the 
protein-DNA interaction should be in part or entirely shifted. Alternatively, binding of 
the antibody to the protein may in tum block binding to the probe. For this analysis, two 
separate antibodies targeted against pea3 and other ets proteins are used (figure 26). The 
pea3 antibody was a mouse monoclonal that is specific for the human pea3 protein. The 
other antibody was a mouse monoclonal that is targeted against the human Etsl and Ets 2 
transcription factors and is cross-reactive with other members of the ets family of 
transcription factors.
In these experiments, no difference was observed in the presence of either 
antibody. This could be explained by the presence of several proteins binding to this 
region of the promoter. The interaction of these proteins with the target protein may 
obstruct the binding of the antibodies to their ligand. Alternatively, a cellular protein that 
was not recognized by the antibodies is binding to the gH promoter. For example, it 
could be a member of the ets family that is not cross-reactive with this antibody or it 
could be an unrelated cellular protein that recognizes a similar binding site.
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PEA3 ab ETS ab SP1
FIG 26. Gel supershift analysis of protein binding to the gH promoter. A probe 
containing sequences from +16 to +35 was used to analyze protein binding to the 
consensus PEA3 binding site (+22 to +28) in the gH" promoter. Monoclonal antibodies 
were used that were specific for PEA3 (PEA3 ab), crossreactive with several of the 
members of the ets family of transcription factors (ETS ab), and specific for Spl (SP1 
ab) to attempt to supershift any of the bands present. The PEA3 and ETS antibodies 
were added in increasing concentrations from 1-3 ug and 3ug of Spl antibody was 
used as a negative control.
Overall, the evidence presented in this chapter gives several insights into the 
mechanisms controlling expression from the HCMV gH promoter. In the context of the 
assays used, the -38  to +35 region of the promoter is primarily responsible for activation 
by the promoter (figure 8). Mutational analysis indicates that a PEA3 element is 
important for control of expression (figure 11). Binding analysis demonstrates that there 
is a protein binding to the PEA3 element (figure 25). The binding of this cellular protein 
is disrupted at late times after infection indicating that this could be a repressor protein
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binding to this region. Additional potential repressor proteins were also identified in gel 
shift analysis (figure 23). Mutation of sequences between the PEA3 element and the 
TATA box had only minor effects on activation by the promoter (figure 15) but DNA 
binding analysis reveals that there are multiple proteins binding to this region (figures 22 
and 23). This could indicate multiple proteins binding that are functionally redundant 
and mutation of sequences within this region only slightly destabilizes the transcription 
initiation complex and does not significantly reduce activation by the promoter. Data 
presented in this chapter also implicate upstream sequences as control elements (figure
9). DNA binding analysis to these sequences suggests a complex pattern of protein- 
protein interaction among these regulatory proteins (figures 18-20).




Gene expression in HCMV infected cells is a very complex regulated process that 
is controlled by both viral and cellular proteins. The goal of this study was to 
characterize the promoter of the late gene that expresses HCMV glycoprotein H to 
address the regulation of HCMV late gene expression. The results generated in this study 
indicate that sequences downstream of the TATA element are primarily responsible for 
activation of transcription in fibroblasts. Further analysis shows that there is a dominant 
downstream control element that masks the effect of control elements upstream of the 
TATA box. Mutational analysis of the gH promoter indicated that the PE A3 element 
plays a significant role in regulation of the promoter expression. Binding analysis also 
demonstrated proteins binding to the PEA3 element and the consensus DAS element 
previously described. Binding analysis also demonstrated several proteins binding to the 
minimal promoter sequences between -38 and +35 as well as to upstream control 
elements between -117 and -38. Promoter sequences that are downstream of the mRNA 
cap site could also be involved in post-transcriptional regulation of gene expression. The 
G-C rich 5' untranslated region could generate secondary structure that represses 
translation as is seen with pp28 (Kerry et al., 1997a) or could affect mRNA stability. 
However in this study we focused on the transcriptional regulation of gH expression.
The data obtained from this study will now be discussed along with the data obtained 
from the study of two other HCMV late genes, pp28 (Kerry et al., 1997b; Kohler et al., 
1994) and UL94 (Wing, Johnson, and Huang, 1998), in the context of a general model of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
92
HCMV late gene regulation. This model addresses three possible mechanisms that 
potentially restrict late gene expression until after viral DNA replication: 1) The structure 
of the viral DNA and the promoter itself somehow restricts late gene expression until 
after the naked viral DNA has been replicated, 2) There is a viral or cellular protein 
responsible for activation that is only present or whose expression is significantly 
increased after viral DNA replication, or 3) There is a viral or cellular repressor protein/s 
that binds to the viral DNA and blocks activation of transcription until after viral DNA 
replication. These mechanisms are not mutually exclusive, and each of them may 
contribute to the regulation of late gene expression. Each of these regulatory mechanisms 
will be addressed in this chapter.
Control of Viral Late Gene Expression Through Viral DNA Structure
The transcriptional control of viral late gene expression through viral DNA 
structure was not directly addressed in this study, but due to its potential importance in 
control of late gene expression, it will be addressed here. One of the most convincing 
arguments that viral DNA structure was important for the control of late gene expression 
is derived from the data obtained in the analysis of the HCMV pp28 promoter. In these 
initial experiments, the control of pp28 gene expression was assessed in transient assays 
(Depto and Stenberg, 1992). These studies demonstrated that the pp28 late gene 
promoter could be activated at early times in the context of transfection superinfection 
assays. Further investigation showed that when some of the same pp28 promoter-CAT 
constructs were incorporated into the vims, the expression of CAT was again restricted to 
late times after infection (Kohler et al., 1994). The reason for this was not known, but 
promoter DNA structure in the context of the vims is a logical explanation. This
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promoter structure could be caused by the high G-C content present in all of the HCMV 
late gene promoters analyzed thus far. The potential secondary structure caused by this 
high G-C content could be relieved when the viral DNA replicates. The bacterial 
plasmids in which the transient assays are performed may not provide the appropriate 
architecture for this secondary structure to form and allow activation to occur. The 
promoter within the viral architecture may have a different pattern of methylation that 
may contribute to control of late gene expression. This activation may be regulated by 
the same transcriptional control elements, but because o f the lack of secondary structure, 
these elements are more accessible and therefore the promoter can be activated at early 
times. There is one study that has addressed the activation of a late promoter in the 
context of a plasmid vector. In this study, the origin of HCMV DNA replication was 
cloned into a vector containing a promoter that can activate the transcription of a 1.2 kb 
RNA at late times. In transfection superinfection experiments with the plasmid 
containing the origin of replication and the promoter, the RNA was transcribed at late 
times (Wade and Spector, 1994). When the origin of replication was disrupted, the 
temporal regulation was lost. These data further indicate that the architecture of the viral 
DNA may play a role in activation of late genes.
Recent evidence suggests that incorporation into the viral genome is not necessary 
to activate the expression of the pp28 promoter at late times (Wu, O'Neill, and Barbosa, 
2001). In this study, the pp28 promoter was incorporated into the U373 host cell genome 
driving the expression of a luciferase reporter. When the pp28 promoter was 
incorporated into the cellular genome, the reporter was expressed with late kinetics to 
wild type levels. The activation of expression was restricted to infection by HCMV,
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because infection by HS V did not activate expression from the pp28 promoter. The 
cellular genome that contains the pp28 promoter construct may, unlike the bacterial 
plasmid backbone, provide the appropriate architecture for restriction of expression to 
late times of infection. Interestingly, these studies demonstrated that cellular DNA 
replication was insufficient to activate pp28 promoter, meaning that expression from the 
pp28 late gene promoter is not regulated by DNA replication itself, but by a viral protein, 
a cellular protein activated at late times of infection, or a combination of both.
Together, these data suggest that the structure of the viral DNA is not exclusively 
responsible for the control of HCMV late gene expression. These data further indicate 
that infection with HCMV is necessary to activate expression to wild type levels. This 
effect is likely due to either a cellular protein whose expression is activated by viral 
infection or by a viral protein. The activation and repression of HCMV gH gene 
expression is discussed in the following sections.
Activation of HCMV Late Gene Expression
The activation of HCMV gH gene expression was analyzed in a transient in vitro 
system. The data obtained in this study agrees with much of the data obtained from the 
analysis of two other HCMV late gene promoters. The main similarity between the three 
HCMV promoters studied is that little sequence upstream of the TATA element is 
required to activate gene expression to wild type levels. In all of these promoters, 
sequences downstream from the 5’ mRNA cap site have a significant role in the 
activation of HCMV late gene expression.
Evidence presented in the study of the UL94 promoter indicates that sequences 
between +2 and +130 contain a dominant downstream activation domain. When this
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region is deleted from the UL94 promoter, activity is reduced by 60% (Wing, Johnson, 
and Huang, 1998), indicating that this region is involved in activation. Further deletion 
analysis of the UL94 promoter localized the downstream activation domain to between 
+2 and +48 relative to the cap site. However, specific sequence elements responsible for 
this activation were not directly addressed in the published report.
The pp28 promoter has been characterized in both transient assays (Depto and 
Stenberg, 1992) and in a genomic context (Kerry et al., 1997a; Kohler et al., 1994).
These studies indicated that sequences upstream of the TATA element could be deleted 
with no significant loss of activation by the promoter. The specific elements responsible 
for pp28 promoter activation were not directly addressed. Comparison of the transient 
transfection studies versus the recombinant vims studies revealed that the temporal 
regulation of late gene expression was disrupted when the pp28 promoter was removed 
from the vims by causing the pp28 late gene promoter to activate expression at early 
times of infection. The exact reason for this intriguing effect is not known, although the 
earlier discussion did offer a possibility that DNA stmcture plays a role in restriction of 
late gene expression to after viral DNA replication. There is also the possibility that there 
are one or more viral or cellular proteins in addition to DNA stmcture that is responsible 
for this effect.
As described earlier, the data obtained in this analysis of the gH promoter was 
consistent with much of the data from the UL94 and pp28 promoters. The deletion 
analysis of this promoter, like the other HCMV late gene promoters, showed that 
sequences downstream from the TATA element were primarily responsible for activation 
by the gH promoter. Specifically, sequences from —38 to +35 were found to be sufficient
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for activation (figure 8). Sequences between +14 and +35 were also deleted from the gH 
promoter in the context of each of the 5’ deletion mutants and revealed the presence of 
potential activation and repression domains in sequences upstream of the TATA element 
(figure 9). These data are quite similar to the data obtained in the analysis of the UL94 
promoter. The dominant activation sequences between +14 and +35 in the gH promoter 
mask the effects of control elements present upstream of the TATA element. The reason 
for this is likely the variety of cell types that HCMV infects in vivo and the different 
transcription factors that are present in these cell types. This effect will be discussed later 
in this section.
In contrast to the earlier studies, this analysis of the gH promoter did identify a 
specific sequence element responsible for activation of the gH promoter. Our studies 
identified a PEA3 element within the minimal promoter that appeared to be responsible 
for gH promoter activation. This PEA3 site was located at +23 to +28 relative to the 
UL75 mRNA cap site (figure 6). The PEA3 transcription factor is a member of the ets 
family of proto-oncogenes. The presence of an ets transcription factor binding site within 
the gH promoter is significant because ets proteins have been shown to be involved in the 
regulation of the HCMV UL4 early gene promoter (Chen and Stinski, 2000). Different 
members of the ets transcription factor family can bind to the same core sequence with 
similar affinities. The specific ets protein that binds to a particular sequence can depend 
on the sequence surrounding the core sequence and other proteins binding to adjacent 
regions (Janknecht and Nordheim, 1993). Mutational analysis of the PEA3 element 
demonstrated that this element is responsible for activation (figure 11). Surprisingly, 
deletion of the same region resulted in a gH promoter construct that could be activated to
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equivalent levels as the wild type promoter (figure 9). Protein binding analysis of this 
region indicated that there are one or more proteins binding to the PEA3 element 
indicated by a single band on a gel shift that is lost when a probe containing mutations in 
the PEA3 element is used (figure 25). Competition analysis on this same gel shift 
supports this finding and also demonstrates that there are proteins binding to sequences 
surrounding the PEA3 element. Our hypothesis is that PEA3 binding is required for 
activation in the presence of surrounding sequences because it is potentially competing 
for binding with a repressor protein. In the absence of PEA3 binding such as in the PX 
mutant, a repressor binds to an adjacent or overlapping element and blocks activation of 
transcription. When PEA3 binding occurs the promoter is active. This hypothesis is 
supported by comparing the mutational (figure II)  and deletion analysis (figure 9) and in 
direct binding analysis (figure 25). Intriguingly, HCMV actively replicates and expresses 
gH in fibroblasts and epithelial cells that express PEA3. However, PEA3 is not found in 
monocytes, the cell type which is latently infected with HCMV (Fisher, Ghysdael, and 
Cambier, 1991). This indicates that different cellular transcription factors are required 
for activation in different cell types and could account for the upstream sequences 
involved in activation.
Additional sequences also contribute to activation by the gH promoter upstream 
of the +14 to +35 dominant control element, based on the fact that sequences from -38 to 
+14 can activate transcription to near wild type levels. Scanning mutants of this region 
were generated to determine which of the sequence elements present within this region 
are responsible for activation. The results of these experiments demonstrated that there is 
no one sequence element within this region that is responsible for activation of the gH
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promoter (figure 15). This is supported by the DNA binding data obtained from this 
region. There were multiple bands present representing proteins binding to probe DNA 
containing all or portions of the -38 to +35 promoter fragment (figures 22-26). The 
multiple proteins that are binding could be redundant activation elements that can activate 
transcription in the absence of one of the other activation elements. The purpose for this 
would be the ability of the viral promoter to be activated in the multiple cell types that 
HCMV infects in which one or more cellular transcription factors may be absent. The 
data obtained in this study still only identified a PEA3 element that is partially 
responsible for promoter activation in fibroblasts. None of these studies of HCMV late 
gene promoters have accomplished this. A novel way to begin to identify proteins 
binding to and activating transcription would be to extract the bands generated on gel 
shifts using probes containing wild type sequences and run the products on a denaturing 
acrylamide gel to determine the number and size of the proteins binding. This preliminary 
analysis could offer a starting point to identifying the exact factors responsible for 
activation of transcription.
Analysis of herpes simplex virus (HSV) late gene promoters has demonstrated 
that like HCMV, transcriptional control elements upstream of the TATA box have 
limited effects on activation of late gene promoters. One HSV late gene promoter has 
been studied in depth and will be directly compared to the gH promoter. Activated 
transcription from the HSV UL38 late promoter requires a TATA box, an initiator 
element (inr) and a downstream activating sequence (DAS) (Guzowski, Singh, and 
Wagner, 1994; Guzowski and Wagner, 1993). The TATA box and the inr element define 
the boundaries of the minimal promoter and the DAS is required for activated
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transcription (Guzowski, Singh, and Wagner, 1994; Guzowski and Wagner, 1993). The 
DAS element is similar in function to the Drosophila downstream promoter element 
(DPE). The DPE has been shown to interact with TAFn60, which could in tum stabilize 
the transcription initiation complex. Interestingly, the HSV UL38 DAS has also been 
shown to bind either TAFn60 or the human homolog, TAFn70 (Wagner, personal 
communication). This suggests that similar mechanisms are regulating expression from 
promoters containing the DAS and DPE elements. This interaction with TAFu70 could 
also occur with the HCMV UL75 promoter and a comparison of the potential binding to 
the HSV UL38 and the HCMV UL75 (gH) promoters is shown in figure 27.
HSVUL38
+33TAFino* 1 ,7 1, 1 ■1-31
DAS+1 Inr +9 +20TATA
HCMV UL75
TFHD TAFII70
TATA +1 DAS +6 +23 PEA3 +28
FIG 27. Comparison of the HSV UL38 promoter and the HCMV UL75 (gH) promoter. 
The top figure is a diagram of the HSV UL38 including critical binding elements and 
binding factors. The bottom figure is a schematic representation of the HCMV gH 
promoter with potential binding factors indicated. All coordinates in the diagram are 
relative to the transcription start site in each promoter.
The comparison in figure 27 shows the HSV UL38 and HCMV gH promoter 
along with potential binding factors. The DAS core sequence originally identified in the 
HSV UL38 promoter was found in the HCMV gH promoter at +1 to +6 (figure 27).
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Additional similarities between the HCMV gH promoter and the prototypical HSV late 
gene promoter UL38 exist. Both the HCMV UL75 gene (gH) and the HSV UL38 gene 
are expressed with true late kinetics from their respective genomes and both of the 
promoters are bidirectional. The promoter for HSV UL38 also activates transcription of 
HSV UL37 in the opposite direction (Flanagan et al., 1991; Goodart et al., 1992). Based 
on preliminary data not presented in this dissertation, the sequence that contains the 
HCMV gH promoter also activates transcription of the HCMV UL76 gene in the opposite 
direction.
As shown in figure 27, the HSV UL38 DAS sequence is downstream from the 
mRNA cap site as opposed to the location of the DAS core consensus element present in 
the gH promoter is immediately adjacent to the UL75 mRNA cap site (figure 6) mapped 
in this study (figure 5). Mutation of the DAS element in the gH promoter had no 
significant effect on promoter activation (figure 13) indicating that this element is not 
important for activation of the gH promoter in fibroblasts. The results presented for the 
HSV UL38 promoter show that the DAS element is necessary for activated transcription. 
This implies that the DAS element is important in the HSV UL38 promoter and not in 
activation by the HCMV gH promoter, however, DNA binding analysis demonstrates 
protein binding to both elements. In figure 27, TAFn70 is shown binding to the DAS 
element in both promoters, although this has only been demonstrated in the HSV 
promoter (Wagner, personal communication).
The interaction between the basal transcription complex and promoter DNA likely 
stabilizes the basal transcription complex. In the gH promoter this interaction could be 
further stabilized by the interaction of TAFh70 with the PEA3 protein and could serve a
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similar purpose to the inr element present in the UL38 promoter, which is not present in 
the gH promoter. A member of the ets family of transcription factors containing a 
domain that is identical to a domain found in the PEA3 protein, was demonstrated to 
directly interact through this domain with TAFn60, the drosophila homolog of TAFh70 
(Defossez et al., 1997). Thus, PEA3 binding in fibroblasts may be sufficient to recruit 
TAFh70. In other cell types where PEA3 levels are lower, the presence of the DAS 
element may allow for the recruitment of the basal transcription complex or other 
transcription factors and help initiate transcription. The DAS element cannot be 
eliminated as being important for some level of control of the gH promoter based on 
DNA binding data. The binding of protein to the DAS element in the gH promoter may 
not be significant in fibroblasts but is potentially important for promoter activation in 
other cell types that are infected in vivo by HCMV. This could be tested by performing 
the identical analysis described in a monocyte cell line that is permissive for infection 
with HCMV. There are also, as yet unidentified, proteins that are responsible for the 
activation of the gH promoter. Based on DNA binding data obtained in this study, these 
unidentified proteins are likely cellular proteins (figure 17) and viral proteins.
There were regions of the promoter upstream of the TATA element that had some 
effect on promoter activation (figure 9). These regions include potential activation 
domains present between -245 to -117 and -81 to -38. The region containing sequences 
between -245 and -117 contains a consensus CAAT enhancer binding protein (C/EBP) 
element that could act in conjunction with the proteins that could bind to the CAAT 
element present in the region of the promoter containing sequences -81 to -38. DNA 
binding analysis of the -80 to -38 promoter sequences revealed a protein binding that
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could represent an activator (figure 18, band a’). Activation from these elements may 
only be necessary in the absence of the dominant downstream control element. A 
situation where activation from these elements may be necessary would be in a cell type 
that does not contain the positive factor binding to the PE A3 element, such as monocytes 
where the PEA3 binding factor is not present.
Repression of HCMV Late Gene Expression
As demonstrated by this study, activation of HCMV late gene promoters is a 
complex process. The reason for this complexity is that the vims infects many cell types, 
including monocytes where it remains latent. Viral promoters including late gene 
promoters are not active during latency. Even if IE and E promoters are active, if late 
genes are not expressed, then viral replication is blocked. Expression of viral late genes 
and subsequent translation of the late structural proteins represents a commitment to the 
completion of the viral replication cycle. In order to control the expression of these late 
proteins, numerous mechanisms are present in late gene promoters to insure that late 
genes are only expressed in a favorable environment for viral replication. In order to 
regulate this expression at this level, sequence elements are present in HCMV late gene 
promoters that repress expression of late genes to insure that the late genes are only 
expressed when necessary.
Repression of HCMV late gene expression is necessary to insure that these late 
genes are only expressed when viral replication progresses past viral DNA replication. 
There is likely a combination of factors that is responsible for this repression including 
DNA stmcture and repressor protein binding directly to late gene promoter sequences and 
repressing transcription. The study describing the characterization of HCMV UL94
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directly demonstrates the presence of repression elements upstream of the TATA element 
to which cellular p53 and viral EE86 are binding and repressing transcription (Wing, 
Johnson, and Huang, 1998). The repression mediated by EE86 and p53 is only evident in 
the absence of a downstream positive regulatory element that is present between +2 and 
+48. These data are similar to our findings obtained in this analysis of the gH promoter.
Sequences upstream of the TATA element in the gH promoter not only contained 
the potential activation domains, but a potential repression domain present between —117 
and —81. Interestingly, the only consensus transcription factor binding element present in 
this region is a ylRE, which has been described as an element that is responsible for 
transcriptional repression in the HCMV UL98 early gene (Jervey, personal 
communication). Analysis of cellular gene expression in the context of HCMV infection 
has demonstrated that genes involved in y-interferon response pathways are activated in 
response to viral infection (Zhu, 1998). DNA binding analysis of this region indicates 
that there are numerous proteins binding to this region and possibly a protein responsible 
for repression (figure 17, bands a and b).
As mentioned earlier, the comparison of mutational analysis of the PEA3 element 
versus deletion of this element indicates the possible presence of repression element 
either adjacent to or overlapping the PEA3 element. Gel shift analysis to probes 
containing this region demonstrates that one or more proteins binding to this region, 
possibly masked during the binding of proteins responsible for promoter activation, could 
repress transcription. In future experiments, to identify proteins binding in the absence of 
the PEA3 element, gel shift analysis using the PX probe (figure 21) will be performed, 
followed by excision of the bands and electrophoresis of the proteins from these bands in
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a denaturing acrylamide gel. Based on the size of binding proteins identified, western 
blots could be performed using antibodies to known cellular and viral transcription 
factors of the same sizes. This could begin the identification of proteins responsible for 
repression binding in the absence of PEA3.
The analysis of the gH promoter presented here indicates that the control of 
transcription from by this promoter is a complex process that is regulated at many levels. 
The structure of the DNA could play a limited role in the control of gH expression.
Future studies addressing this issue could include the generation of recombinant viruses 
containing gH promoter reporter constructs such as those generated for the studies of the 
pp28 promoter. A simpler method for generating these recombinant viral constructs 
could be used such as generating these viruses in bacterial artificial chromosomes. These 
recombinant viral constructs can also be used in future analysis of the gH promoter to 
further elucidate the mechanisms of activation and repression. The data obtained in this 
study in combination with the data obtained in future analysis of the gH promoter in the 
brief description of possible future studies will facilitate understanding of the 
mechanisms responsible for gH promoter control.




The data presented in this study have demonstrated that regulation of the gH 
promoter is a complex event that involves numerous proteins involved in activation 
repression of gH gene expression. Figure 28 below shows a basic model that represents 










FIG 28. Model for control of transcription by the gH promoter. The minimal promoter 
activates transcription in the presence of a specific late viral protein whose presence has 
been suggested in gel shifts. These gel shifts have also suggested several proteins 
binding to these promoter sequences, likely as a complex. In the inactive state, data 
suggest that some protein binding may be interrupted, but there are still proteins binding, 
even to the sequence immediately surrounding the PEA3 element, a region that data 
suggest is important for transcriptional control.
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This model represents the data obtained in the analysis of the sequences between 
-38 and +35, which represents the minimal promoter. The conclusions generated from 
the gH promoter are as follows:
1) The PEA3 element is involved in the activation of the gH promoter. When this 
element is mutated a repressor binds to adjacent or overlapping promoter 
sequences and blocks promoter activation.
2) Protein binding to the DAS element was demonstrated though the DAS element 
was not shown to be significant for promoter activation in fibroblasts.
3) Multiple elements between -38 and +14 are involved in gH promoter activation. 
These elements function in combination to activate transcription to maximal 
levels.
4) Sequences between +14 and +35, including the PEA3 element contain a dominant 
activation domain.
5) Sequences upstream of the TATA element between -245 and -38 contain 
transcriptional control elements functional in the absence of the dominant 
downstream activation domain.
6) The presence of a specific protein binding to promoter sequences between +1 and 
+35 at late times of viral infection was demonstrated and this binding likely 
occurs to activate transcription.
The data used to arrive at these conclusions was combined with the data from the
analysis of other HCMV late gene promoters to generate a model of HCMV late gene
expression. This model shows that the regulation of transcription from HCMV late
gene promoters is a complex process. The different cell types that are infected by
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HCMV likely necessitate this complex regulation. Future analysis of the gH 
promoter will likely be performed in the context of recombinant viruses or in other 
cell types.
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